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1. Introduction and objectives of the study 
Folic acid is an important nutrient for women in childbearing age. Adequate folate intake 
during the periconceptional period, the time right before and just after a woman becomes 
pregnant, helps protect against a number of congenital malformations including Neural 
Tube Defects (NTDs) which are the most notable birth defects that occur from folate 
deficiency.Folic acid fortification has been considered as a main strategy to control and 
reduce the prevalence of NTDs.  
Micronutrient deficiencies, especially Iron, Zinc, Vitamin A and vitamin D were reported 
as one of the most common nutritional problems in Iran (Ministry of Health &Medical 
Education, 2001). In addition, there are evidence of low intake of calcium and Riboflavin 
at the national level (National Nutrition Institute,2001). 
Food fortification along with the other strategies including supplementation, nutrition 
education and public health measures are being implemented by Ministry of Health and 
Medical Education to prevent and control micronutrient deficiencies, but still the 
prevalence rate of these deficiencies is high. 
Along with the other strategies, mandatory flour fortification with iron and folic acid has 
been considered to improve the micronutrient status of the Iranian population. Wheat 
flour is highly subsidized by the government and it is quite accessible to the whole 
population in urban and rural areas. Bread is an appropriate vehicle for adding iron and 
folic acid in Iran. It is a staple commodity. It is low cost as flour is highly subsidies by 
the Government and is readily available. In overpopulated and poor families that have 
few choices for foods, bread is a staple food.  
For adding folic acid to flour, although, there is not any large scale study on folate status 
in Iran, considering the evidences on the role of folic acid to reduce the occurrence of 
Neural Tube Defects (NTDs) and also available experience on fortification with folic 
acid, it has been decided to add folic acid to wheat flour simultaneously with iron.  
Based on the World Health Organization (WHO) recommendation, 1.5 ppm of folic acid 
is added to the wheat flour that is 150 µg per 100g of flour. 
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No interventional trial on the efficacy and safety of folic acid fortification acid has been 
conducted in Iran .It is necessary to study the efficacy of folic acid fortification with 
regard to folate status, NTDs prevalence and possible risk of masking vitamin B12 
deficiency.  
Recently, the possibility of masking vitamin B12 deficiency due to folate fortification has 
been raised. The reason is that vitamin B12 and folic acid have the same metabolic 
pathway and additional folic acid could mask the hematological signs of vitamin B12 
deficiency postpones clinical diagnosis which could lead to neurological damage. 
Epidemiological studies showed a prevalence of vitamin B12 deficiency of around 20% 
in the general population of industrialized countries (Andres etal, 2004).Globally, the 
prevalence of vitamin B12 deficiency is likely to be higher in developing countries. 
In Iran ,based on the latest national food consumption survey (National Nutrition Institute 
,2001), the average per capita consumption of meat and dairy products as rich sources of 
vitamin B12 is lower than the recommended food basket for Iranian population due to 
high cost or low physical accessibility in deprived areas. So, the possibility of vitamin 
B12 deficiency has to be explored before implementing flour fortification with folic acid 
nationally. 
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1.1. Aims and objectives of the study 
Mandatory flour fortification has been considered a priority to improve the micronutrient 
status of the Iranian population. There was no interventional trial on the efficacy and 
safety of folic acid fortification by adding 1.5 ppm of folic acid to wheat flour in Iran. In 
the presented research, we studied the efficacy of folic acid fortification on NTDs 
prevalence and possible risk of masking vitamin B12 deficiency in child bearing age 
women with the following objectives:  
1. To determine the prevalence rate of serum folate deficiency before and after flour 
fortification 
2. To determine the  Mean serum folate before and after flour fortification 
3. To determine the prevalence rate of serum Vitamin B12 deficiency before and 
after flour fortification 
4. To determine the Mean serum Vitamin B12 before and after flour fortification 
5. To determine the prevalence rate of the high  homocysteine  levels  before and 
after flour fortification 
6. To determine the mean serum homocysteine before and after flour fortification 
7. To determine the  prevalence rate of low serum vitamin B12 without macrocytosis 
before and after  flour fortification  
8. To determine the incidence rate of NTD before and after flour fortification 
9. To determine the prevalence rate of folate intake deficiency before  
            and after flour fortification . 
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2. Litreture review 
 
2.1. Folic acid (Pteroylmonoglutamate) 
 
2.1.1. Biochemistry and metabolism 
Folic acid, the more stable form, rarely is founded in foods or the human body but is the 
form most often used in vitamin supplements and fortified foods. Folates are found in 
foods as well as metabolically active forms in the human body (National Academy of 
Sciences, 2000). 
Folate is a general term related to a family of substances containing a pteridine ring 
joined to both p-aminobenzoic acid and glutamic acid (Goh and Koren , 2008). Reduced 
forms of this molecule are called dihydrofolate and tetrahydrofolate.  
In the form of a series of tetrahydrofolate (THF) compounds, folate derivatives are 
substrates in a number of single-carbon-transfer reactions, and also are involved in the 
synthesis of dTMP (2′-deoxythymidine-5′-phosphate) from dUMP (2′-deoxyuridine-5′-
phosphate). It is a substrate for an important reaction that involves vitamin B12 and it is 
necessary for the synthesis of DNA, and so required for all dividing cells (Goh and 
Koren, 2008). The pathway leading to the formation of tetrahydrofolate (FH4) begins 
when folate (F) is reduced to dihydrofolate (DHF) (FH2), which is then reduced to THF. 
Dihydrofolate reductase catalyses the last step (Arinz, 2005). As the active form, THF, 
folate plays a role in a variety of reactions include: 
2.1.1.1 one -carbon metabolism 
The only function of folate coenzymes in the body appears to be in mediating the transfer 
of one carbon unites (Choi and Mason 2000). Folate coenzymes act as acceptors and 
donors of one-carbon units in a variety of reactions critical to the metabolism of nucleic 
acids (RNA and DNA), cell division and certain amino acids (Baily etal., 2003). 
2.1.1.2. Nucleic acid metabolism 
Folate coenzymes play a vital role in DNA metabolism through two different pathways. 
1) The synthesis of DNA from its precursors (thymidine and purines) is dependent on 
folate coenzymes. 2) A folate coenzyme is required for the synthesis of methionine, and 
methionine is required for the synthesis of S-adenosylmethionine (SAM). SAM is a 
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methyl group (one-carbon unit) donor used in many biological methylation reactions, 
including the methylation of a number of sites with in DNA and RNA (Arinze, 2005). 
 Some of the important reactions in which SAM is involved are: 1) Methylation of DNA 
and RNA. DNA- and RNA-methylases use SAM as a source of methyl groups. A major 
target of methylases is the 5 position of cytosine of DNA. The degree of methylation 
correlates with transcriptional activity. 2) The conversion of epinephrine to 
norepinephrine is also catalyzed by an N-methyl transferase that uses SAM. The product 
after the methyl group is transferred is S-adenosyl-homocysteine. Hydrolysis gives 
homocysteine and adenosine (Figure 1).   
1.1.2.3. Amino acid metabolism 
Folate coenzymes are required for the metabolism of several important amino acids such 
as methionine, histidine, serine, and glycine .The synthesis of methionine from 
homocysteine requires a folate coenzyme as well as a vitamin B12-dependent enzyme 
(Baily etal., 2003). 
 
 Figure 1: Folate metabolic cycle. 
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In vitamin B12 deficiency there is a buildup of the substrate, N5-methyl-THF which 
cannot be re cycled. This causes a deficiency of the other forms of THF which are needed 
for other reactions, particularly in DNA synthesis. The loss of THF forms due to the 
inability to use methyl-THF is referred to as "the methyl trap." 
2.1.2. Functions 
2.1.2.1. Human Reproduction 
Adequate folate intake during the periconceptional period, the time just before and just 
after a woman becomes pregnant, helps protect against a number of congenital 
malformations including Neural Tube Defects (NTDs) ( Stevenson, 2000).  
The protective effect of folate during pregnancy goes beyond NTDs. Supplementation 
with folic acid has been shown to reduce the risk of congenital heart defects, cleft palate, 
limb defects and urinary tract anomalies(Goh and Koren, 2008) .A statistically significant 
association between high folate intake and lower sperm aneuploidy has been explored 
(Young etal.,2008).  
2.1.2.2. DNA and cell division 
Folate is needed to synthesize DNA bases (most notably thymine, but also purine bases) 
and also needed for DNA replication. Thus, folate deficiency hinders DNA synthesis and 
cell division. Since folate deficiency limits cell division, erythropoiesis, production of red 
blood cells is hindered and leads to megaloblatic anemia which is characterized by large 
immature red blood cells.  
2.1.3. Dietary recommendations 
The Dietary Reference Intake (DRI) for folate are expressed in a term called the Dietary 
Folate Equivalent .The Dietary Folate Equivalent (DFE) was developed to help account 
for the differences in absorption of naturally occurring dietary folate and the more 
bioavailable synthetic folic acid .1 μg of DFE is equivalent to 1 μg food folate that is 
equivalent to 0.5 μg of folic acid (pteroylmonoglutamate) taken on an empty stomach .It 
is equal to 0.6 μg folic acid from supplements and fortified foods. DRI for women in 
childbearing age has been suggested equal to 400 μg/day, while for pregnant women is 
600 μg/day and for lactating women is equal to 500 μg/day (National Academy of 
Sciences, 2000).  
 16
2.1.4. Absorption, Transport, and Storage 
 
Different forms of food folate including pteroylmonoglutamate and pteroylpolyglutamate 
and their absorption are depended on different conjugates and oxidation states.  
The monoglutamate form of folate is actively transported across the proximal small 
intestine. Monoglutamates, mainly 5-methyl-tetrahydrofolate, are present in the portal 
circulation. Much of this folate can be taken up by the liver, where it is metabolized to 
polyglutamate derivatives and retained or released into the blood or bile.  
Folate concentrations in the liver were reported up to 4.5 μg /g after liver biopsies. 
Because the adult male liver weighs approximately 1,400 g, the total quantity of folate in 
the liver would be approximately 6 to 14 mg. If the liver is assumed to contain 50 percent 
of the body stores of folate, the estimated total body folate store would be 12 to 28 mg 
(National Academy of Sciences, 2000). 
2.1.5. Bioavailability 
When consumed under fasting conditions, supplements of folic acid are nearly 100 
percent bioavailable (Gregory, 1997). Overall, different studies indicate that folate added 
to cereal-grain foods is highly available and efficacious. From these experimental data 
the bioavailability of folic acid consumed with food is estimated to be 85 percent. Studies 
have not been conducted to define the bioavailability of folic acid consumed with entire 
meals. It is assumed that the bioavailability would be somewhat lower than that observed 
with folic acid alone or with a small portion of food. Bioavailability of food folate has 
been reported no more than 50 percent that of folic acid (National Academy of Sciences, 
2000). 
 
2.1.6. Clinical effects of folate deficinecy 
Inadequate folate intake first leads to a decrease in serum folate concentration, then to a 
decrease in erythrocyte folate concentration, a rise in homocysteine concentration, and 
megaloblastic changes in the bone marrow and other tissues with rapidly dividing cells. 
When folate supply to the bone marrow becomes rate limiting for erythropoiesis, 
macrocytic cells are produced. However, because of the 120-day lifespan of normal 
erythrocytes, macrocytosis is not evident in the early stages of folate-deficient 
 17
megaloblastosis. As folate depletion progresses further, the mean cell volume increases 
above normal. 
2.1.7. Causes of deficiency 
2.1.7.1. Inadequate ingestion of folate-containing foods 
Poor nutrition is prevalent among people with alcoholism (Allen 2008) and patients with 
psychiatric morbidities (Edeh and Toone, 2007) as well as elderly people (due to 
conditions such as ill-fitting dentures, physical disabilities, and social 
isolation).Moreover, for patients with renal (Karaku etal., 2004) and liver failure, 
anorexia and restriction of foods rich in protein, potassium, and phosphate contribute to 
decreased folate intake.  
2.1.7.2. Impaired absorption  
Celiac disease and tropical Sprue cause villous atrophy. The process of aging causes 
shorter and broader villi in 25% of the elderly population. Achlorhydria leads to elevation 
of gastric PH above the optimal level (i.e., PH of 5) for folate absorption. Anticonvulsant 
drugs, such as Dilantin, interfere with mucosal conjugates, hence impairing folate 
absorption. Other nutrient deficiencies such as zinc, riboflavin (vitamin B2), niacin 
(vitamin B3) and vitamin B12 may affect folate absorption and metabolism (Tapan etal., 
2003).  
2.1.7.3. Impaired metabolism 
Antimetabolites that are structurally analogous to the folate molecule can competitively 
antagonize folate utilization. Methotrexate and trimethoprim both are folate antagonists 
that inhibit dihydrofolate reductase (National Academy of Sciences 2000). 
Hypothyroidism has been known to decrease hepatic levels of dihydrofolate reductase as 
well as methylene THFA reductase. People with alcoholism can have very active alcohol 
dehydrogenase that binds up folate and thus interferes with folate utilization (Tapan etal., 
2003).  
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2.1.7.4. Increased excretion /loss 
During vitamin B-12 deficiency, methylene THFA is known to accumulate in the serum, 
which is known as the folate trap phenomenon. In turn, large amounts of folate filter 
through the glomerulus, and urine excretion occurs.  
2.1.7.5. Increased destruction  
Superoxide, an active metabolite of ethanol metabolism, is known to inactivate folate by 
splitting the folate molecule in half between the C9 and N10 position. The relationship 
between cigarette smoking and low folate levels has been noted as possibly due to folate 
inactivation in exposed tissue (Allen 2008). 
2.1.8. Folic acid deficiency Anemia 
Megaloblastic anemia is usually caused by a deficiency of folic acid or vitamin B12 
because both of these nutrients are essential to the synthesis of nucleoproteins .Folate 
deficiency anemia develops in four stages (Kathleen Mahan and Scott-Stump, 2003). 
Stage 1: In this stage, a serum folate level is less than 3ng/ml which is named serum 
folate depletion. In fact, in this stage, an early negative folate balance is occurred. 
Stage 2: This stage is characterized by a negative folate balance that means the cell has 
been depleted and a reduction in red blood cell folate levels to less than 140ng/ml has 
been occurred. 
Stage 3: This stage is associated with a damage of folate metabolism and folate 
deficiency characterized by slowed DNA synthesis. 
Stage 4: This stage is manifested by an elevated mean corpuscular Volume (MCV) and 
anemia that is named folate deficiency anemia. 
Both deficiencies of folic acid and vitamin B12 will results to damage of DNA synthesis 
with the same clinical sign which is megaloblastic anemia. 
2.1.9. Current issues and controversies 
2.1.9.1. Neurological disorders 
 
Several studies suggested that folate deficiency may occur in up to one third of patients 
with severe depression, and that treatment with folic acid may enhance recovery of the 
mental state (Gilbody , 2007 and Botteiglieri etal., 2000). Other studies suggest a link 
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between folate deficiency and impaired metabolism of serotonin, dopamine and 
noradrenalin (norepinefrine) which have been implicated in mood disorders (Botteiglieri 
etal., 2000). One study has shown that higher dietary intakes of folate, vitamin B12, and 
vitamin B6 might decrease the risk of Parkinson Disease through decreasing plasma 
homocysteine (Lau etal., 2006).  
 
2.1.9.2. Cardio Vascular Disease 
Some investigators have hypothesized that increased folate intake will reduce mortality 
from vascular disease and have proposed increases in the fortification level to achieve a 
maximal reduction in serum homocysteine levels (Wald etal., 2002). 
One study suggested that folic acid supplementation may do more harm than good (Lonn 
etal., 2006). As of 2006, studies have shown that giving folic acid to reduce levels of 
homocysteine does not result in clinical benefit. These studies suggests that folic acid in 
combination with B12 may even increase some cardiovascular risks (Zoungas etal., 2006 , 
Bonna etal., 2006).  
 
2.1.9.3. Cancer  
A relationship between folate intake or status and several types of cancers including 
colorectal, breast, cervical, pancreatic, brain and lung cancers has been observed in 
several population based studies (Choi and Mason, 2000). Epidemiologic studies using 
large cohort groups support an inverse association between folate and risk of colorectal 
dysplasia or neoplasia (Baily etal., 2003). A 2006 prospective study of Swedish adults 
found that diets high in folate from foods, but not from supplements, were associated 
with a reduced risk of pancreatic cancer (Larsson etal., 2006). Most epidemiologic 
studies suggest that diets high in folate are associated with decreased risk of breast 
cancer, but results are not uniformly consistent: one large cancer screening trial reported 
a potential harmful effect of high folate intake on breast cancer risk, suggesting that 
routine folate supplementation should not be recommended as a breast cancer preventive 
(Kim., 2006) .One study in 2008 has shown no significant effect of folic acid on overall 
risk of total invasive cancer or breast cancer among women (Zhang etal., 2008). More 
over, the results of the population – based observations from two data sets from the 
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United States and Canada have showen an increase in Colorectal Cancer (CRC) incidence 
after flour fortification with folic acid and hypothesized that the institution of folic acid 
fortification may have been wholly or partly responsible for the observed increase in 
CRC rates. Thetheoreticalconcern is that,the pivotalrole of folatein nucleotide synthesis, 
including its role as a cofactor in a rate limiting step for DNA synthesis ( Wagner,1995), 
also makes it a potential growth factor for neoplastic cells ( Mason etal,2007). 
2.1.9.4. Fertility 
In men, folate contributes to spermatogenesis. In women, on the other hand, it contributes 
to oocyte quality and maturation, implantation, placentation, in addition to the general 
effects of folic acid on fetal growth and organ development (Ebisch etal., 2007) .Wong 
and colleagues found that folic acid administration (5 mg) to sub fertile and fertile men 
resulted in a significant increase of folate concentrations in seminal plasma, but no effect 
of this intervention was observed on sperm count or motility of spermatozoa , however, a 
74% increase in total normal sperm count after intervention with a combination of folic 
acid and zinc sulphate was observed (Wong etal., 2002). 
A study on homocysteine concentrations in follicular fluid in women opting 
for IVF treatment reported that women receiving folic acid supplementation had 
significantly lower homocysteine concentrations in their follicular fluid (the 
microenvironment surrounding the oocyte), a better quality of oocytes and, a higher 
degree of mature oocytes compared with women who did not receive folic acid 
supplementation(Szymanski etal., 2003) . 
2.1.9.5. Macular degeneration 
 
The possible effect of folic acid on macular degeneration has been raised recently. A 
recent sub study of the Women's Antioxidant and Folic Acid Cardiovascular Study 
reported that use of a nutritional supplement that contains folic acid, pyridoxine, and 
cyanocobalamin decreased the risk of developing age –relatedmacular degeneration by 
34% (Christen etal., 2009) .  
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2.1.9.6. Folic acid supplements and masking of B12 deficiency 
 
Reduction in the methylation cycle has multiple effects less easy to identify. One such 
effect is certainly on the nerve cells, because interruption of the methylation cycle 
causing neuropathy can also happen in vitamin B12 deficiency due to reduced activity of 
the vitamin B12-dependent enzyme methionine synthase.  
Folic acid supplements can correct the anemia associated with vitamin B12 deficiency.  
But it will not correct changes in the nervous system that result from vitamin B12 
deficiency. Permanent nerve damage could theoretically occur if vitamin B12 deficiency 
is not treated (Morris etal., 2007).  
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2.2. Vitamin B12 
2.2.1. Terminology 
vitamin B12 refers to a group of cobalt-containing compounds known as cobalamins - 
cyanocobalamin , hydroxocobalamin and the two coenzyme forms of B12, 
methylcobalamin (MeB12) and 5-deoxyadenosylcobalamin (adenosylcobalamin - 
AdoB12). In a more specific way, the term B12 is used to refer to cyanocobalamin, which 
is the principal B12 form used for foods and in nutritional supplements ( Mcdowell,2000).  
2.2.2. Structure 
The structure of B12 is based on a corrin ring, which is similar to the porphyrin ring 
found in heme, and cytochrome. The central metal ion is cobalt. Four of the six 
coordination sites are provided by the corrin ring, and a fifth by a dimethylbenzimidazole 
group. The sixth coordination site, the center of reactivity, is variable, being a cyano 
group (-CN), a hydroxyl group (-OH), a methyl group (-CH3) or a 5’-deoxy adenosyl 
group, respectively, to yield the four B12 forms mentioned above. 
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Historically, the covalent C-Co bond is one of first examples of carbon-metal bonds to be 
discovered in biology. The hydrogenases and, by necessity, enzymes associated with 
cobalt utilization, involve metal-carbon bonds (Lieberman etal, 2007).  
2.2.3. Function 
2.2.3.1. Metabolism function 
Vitamin B12 is normally involved in the metabolism of every cell of the body, especially 
affecting the DNA synthesis and regulation but also fatty acid synthesis and energy 
production. In humans, only two corresponding coenzyme B12-dependent enzymes are 
known:  
1)Methylmalonyl Coenzyme A mutase (MUT) which requires adenosylcobalamin to 
convert L-methymalonyl-CoA to succinyl-CoA to an isomerization reaction. 
   This is an important step in the extraction of energy from proteins and fats. This 
functionality is lost in vitamin B12 deficiency, and can be measured clinically as an 
increased methylmalonic acid (MMA) level (National Academy of Scineces , 2000).  
2)5 – methyltetrahydrofolate – homocysteine methyltransferas (MTR), also known as 
methionine synthase. This is a methyl transfer enzyme, which requires methylcobalamin 
as a cofactor for the methyl transfer from methyltetrahydrofolate to homocysteine to form 
methionine and tetrahydrofolate (Ferrer 2004). 
This functionality is lost in vitamin B12 deficiency, and can be measured clinically as an 
increased homocyteine level in vitro. Increased homocysteine can also be caused by a 
folic acid deficiency, since B12 helps to regenerate the tetrahydrofolate (THF) active 
form of folic acid. Without B12, folate is trapped as 5-methyl-folate, from which THF 
cannot be recovered unless a MTR process reacts the 5-methyl-folate with homocysteine 
to produce methionine and THF, thus decreasing the need for fresh sources of THF from 
the diet (Scalabrino 2006).  
2.2.3.2. Neurological function 
Methylation cycle provide S-adenosyl-methionine (SAM) as a methyl donor to synthesis 
DNA, protein, hormones and lipids .The conversion of epinephrine to norepinephrine is 
also catalyzed by an N-methyl transferase that uses SAM. Interruption of methylation via 
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B12 deficiency leads to demyelination of nerve resulting in a neuropathy (Finkelstein and 
Martin, 2000).Evidence from several studies has demonstrated associations among 
vitamin B-12 status and many aspects of cognition. Clarke found a significant associated 
between low serum concentrations of holo TC and high MMA and a more rapid cognitive 
decline among persons aged 65 y during a 10-years period (Clarke etal., 2007).  
2.2.4. Absorption, transport, storage 
Absorption of food vitamin B12 requires an intact and functioning stomach, exocrine 
pancreas, intrinsic factor, and small bowel. Problems with any one of these organs makes 
a vitamin B12 deficiency possible. It is assumed that 50 percent of dietary B12 is absorbed 
by healthy adults with normal gastric function. A smaller fractional absorption would 
apply, however, if a person consumed a large portion of foods rich in vitamin B12. 
Around 60% of vitamin B12 is stored in the liver (National Academi of Scineces, 2000). 
Due to the extremely efficient enterohepatic circulation of B12, the liver can store several 
years’ worth of vitamin B12. Vitamin B12 deficiency may arise in a year if initial stores 
are low (Zengin etal, 2009). 
2.2.5. Causes of deficiency 
2.2.5.1. Inadequate Consumption 
Restriction or exclusion of all animal foods may result in low intake of certain 
micronutrients such as vitamin B-12, thereby affecting vitamin B-12 status. Overall, the 
studies have shown reduced mean serum vitamin B-12 and elevated mean homocysteine 
concentrations in vegetarians, particularly among vegans (Elmadfa etal, 2009). 
Inadequate intake, due to low consumption of animal-source foods, is the main cause of 
low serum vitamin B-12 in younger adults and likely the main cause in poor populations 
worldwide. In most studies, serum vitamin B-12 concentration is correlated with intake of 
this vitamin (Allen, 2009).  
2.2.5.2. Inadequate Absorption  
Overgrowth of bacteria in part of the small intestine can lead to inadequate absorption. 
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Patients with bacterial overgrowth that is longstanding can develop complications of their 
illness as a result of malabsorption of nutrients including vitamin B12 (McPhee etal., 
2007).  
2.2.5.3. Malabsorption disorders   
Food-cobalamin malabsorption syndrome is characterized by the inability to release 
cobalamin from food or from intestinal transport proteins, particularly in the presence of 
hypochlorhydria, where the absorption of “unbound” cobalamin remains normal. A 
statistically significant relation between H pylori infection and serum vitamin B12 levels 
among boys and girls 5-18 years who underwent upper gastrointestinal endoscopy 
because of dyspeptic symptoms has been reported (Akam etal., 2007). 
Inflammatory bowel disease: Deficiencies of both macronutrients, as well as 
micronutrients such as iron, cobalt, chromium, copper, manganese, selenium , zinc and 
vitamin B12 is a common feature of inflammatory bowel disease (Headstorm etal., 2008).  
Individuals with stomach and small intestinal surgeries may be unable to absorb enough 
vitamin B12.  
Drugs: Acid suppression therapy, including H2-receptor antagonists and proton pump 
inhibitors (Andres etal., 2003) may inhibit B 12 absorption . 
Metformin can interfere with vitamin B12 absorption. The probable mechanism is that 
the B12 –intrinsic factor complex uptake by illeal cell membrane receptors is known to 
be calcium –dependent, and Metformin affects calcium- dependent membrane action. The 
result in B12 deficiency can be reversed by administering calcium, ant it seems to be the 
clearest mechanism (Ting etal., 2006). 
Lack of intrinsic factor: Pernicious anaemia is the most common cause of vitamin B12 
deficiency. It is caused by an autoimmune gastritis that affects the gastric parietal cells, 
leading to the destruction of the gastric mucosa, reduced or absent gastric acid production 
and a lack of intrinsic factor .Intrinsic factor may be lacking because the part of the 
stomach where it is produced was surgically removed (Day, 2006).  
2.2.6. Dietary recommendations  
 
The Dietary Reference Intake (DRI) for adults ranges from 2 to 3 µg per day.The DRI for 
vitamin B12 in pregnant women is 2.6 µg per day and 2.8 µg during lactation periods. 
 26
There is insufficient reliable information available about the safety of consuming greater 
amounts of Vitamin B12 during pregnancy (National Academy of Scineces, 2000). 
2.2.7. Toxicity 
No toxic or adverse effects have been associated with large intakes of vitamin B12 from 
food or supplements in healthy people. Doses as high as 1 mg daily by mouth or 1 mg 
monthly by intramuscular injection have been used to treat pernicious anemia without 
significant side effects. When high doses of vitamin B12 are given orally, only a small 
percentage can be absorbed, which may explain the low toxicity. Because of the low 
toxicity of vitamin B12, no tolerable upper intake levels (UL)) have been set (National 
Academy of Scineces, 2000). 
2.2.8. Epidemiology of Vitamin B12 deficiency 
Traditionally the problem was assumed to be due to strict vegetarianism , however it is 
now apparent that it is also an issue in lacto-ovo vegetarians ( Herman etal., 2001 , 
Majchrzak etal., 2006) , aged population (Floodd etal., 2006) and in those with low meat 
consumption (Allen, 2009). 
Epidemiological studies show a prevalence of cobalamin deficiency of around 20% 
(between 5% and 60%, depending on the definition of cobalamin deficiency used in the 
study) in the general population of industrialized countries (Andres etal., 2004). 
A high prevalence of impaired vitamin B12 status in pregnant Nepalese women has been 
reported. While 61% of the women had elevated s-MMA, and low s-cobalamin values 
were observed in 49% of the women, (Bondevik etal., 2001) . 
The Framingham Offspring Study found up to 39% of U.S. adults at risk for vitamin B12 
deficiency (Tucker etal., 2000). Globally, the prevalence of vitamin B12 deficiency is 
likely to be higher in developing countries. Yajnik found 67% of low vitamin B12 
concentration) among middle - aged men of the South Asian Indians (Yajnik etal., 2006). 
According to the Allen study , more than 40% of the subjects of all ages in Latin America  
had low plasma vitamin B12  and also in Mexico, the prevalence of deficient and 
marginal plasma B12 values respectively was 41% and 16% in preschoolers (18-36 
months), 22% and 25% in school children(7-10 years),19% and 19.5% in non –pregnant 
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women , 19% and 43% in pregnant women,30% and 25% in lactating women , and 27% 
and 15% in adult men(Allen 2004). Ling Hao, found that 11% of healthy Chinese men 
and women 35-64 years old in the southerners and 39% of the northerners were vitamin 
B-12 deficient (Hao etal, 2007)  
2.2.9. Symptoms and damages of vitamin B12 deficiency 
Vitamin B12 deficiency can potentially cause severe and irreversible damage, especially 
to the brain and nervous system. At levels only slightly lower than normal, a range of 
symptoms such as fatigue, depression, and poor memory may be experienced (Sethi etal., 
2005). However, these symptoms by themselves are too nonspecific to diagnose 
deficiency of the vitamin.Vitamin B12 deficiency can also cause symptoms of mania and 
psychosis (Bernal etal, 2007).  
Megaloblastic anemia (pernicious anemia) which results from inhibition of DNA 
synthesis in red blood cell production is often due to deficiency of vitamin B12 and/or 
folic acid. It is characterized by many large immature and dysfunctional red blood cells 
(megaloblasts) in the bone marrow, and also by hypersegmented or multihypersegmented 
neutrophils. 
The neurological complex, defined as myelosis funicularis, consists of the symptoms 
such as impaired perception of deep touch, pressure and vibration, abolishment of sense 
of touch, irritability, focus/concentration problems, depressive state with suicidal 
tendencies and Paraphernia complex. These symptoms may not reverse after correction of 
hematological abnormalities, and the chance of complete reversal decreases with the 
length of time the neurological symptoms have been presented (Sethi etal. 2005). 
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2.3. Neural Tube Defects  
 
2.3.1. Definition 
 
Birth defects (congenital anomalies) are the leading cause of death in babies under 1 year 
of age. Neural Tube Defects (NTDs) are the second most common type of birth defect 
after congenital heart defects which arise during the process of neurulation, between the 
17th and 30th post fertilization days. Depending on the size and the location of the defect, 
the patient can suffer either no physical handicap or life long disabilities (Detrait etal. 
2005). Interruption of DNA biosynthesis or methylation reactions could prevent the 
proper closure of the neural tube. Such inhibition could be caused by simple deficiency of 
either folic acid or vitamin B12. 
 
2.3.2. Types of Neural Tube Defects ( NTDs) 
There are two types of NTDs. The most common are called the open NTDs. Open NTDs 
occur when the brain and/or spinal cord are exposed at birth through a defect in the skull 
or vertebrae (back bones). Examples of open NTDs are spina bifida (myelomeningocele), 
anencephaly, and encephalocele. Rarer types of NTDs are called closed NTDs. Closed 
NTDs occur when the spinal defect is covered by skin. Common examples of closed 
NTDs are lipomyelomeningocele and lipomeningocele (Brand, 2007). 
Spina Bifida Occulta (SBO) is potentially another form of an NTD in which there is a 
typically benign (or non-symptom-causing) bony change in one or more vertebrae, but 
not involving the nerves within the spinal column. The incidence of SBO is not well 
defined; however, it is more common than the NTDs described above (Kaufman 2004).  
 
2.3.3. Causes of NTDs 
Genetic and environmental factors contribute to NTDs. However, it is generally agreed 
that most NTDs cases are of multifactor origin, having a significant genetic component to 
their etiology that interacts with a number of environmental risk factors (Padmanabhan 
2006). NTDs are not only disorders of embryologic induction but also disorders of 
cellular migration and include the secondary mechanical complications that occur with an 
unprotected nervous system (Kashani 2001).  
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2.3.3.1. Genetic causes of NTDs 
 
Several chromosomal and single-gene disorders have been reported to be associated with 
NTDs. Spina bifida occurs more frequently in autosomal trisomies However, no single 
gene, which is solely responsible for NTDs in humans has been defined (Padmanabhan 
2006).  
2.3.3.2. Physical and chemical environment 
Moretti reported significant association between the risk of NTDs and maternal 
hyperthermia exposure (Moretti, 2005) .Maternal infections (e.g. rubella, 
cytomegalovirus, Toxoplasmo gondii, syphilis) (Padmanabhan 2006) and, maternal 
metabolic conditions (e.g. phenylketonuria, diabetes mellitus, endemic cretinism) 
enhance the risk for NTDs (Ray et al., 2004).  
An association between maternal obesity and an increased risk of NTDs-affected 
pregnancy has been reported (Rasmussen and Sonja, 2008). Dugs such as Valproic acid 
have been identified as teratogens. Valproic acid is a known folate antagonist and its 
association with NTDs may be through that action (Duncan et al., 2001). 
2.3.3.3 .Nutritional factors 
Zhang found significantly lower serum concentrations of 5- methyltetrahydrofolate (5-
MeTHF), 5-formyltetrahydrofolate (5-FoTHF), total folate and vitamin B12 in NTDs 
affected pregnancies compared to the controls and concluded that these compounds could 
be identified as potential risk factors for NTDs early diagnosis (Zhang etal.,2008). 
In addition to low folate levels or polymorphisms in folate metabolizing enzymes, lower 
vitamin B12 concentrations during pregnancy may also be independently contributing to 
an increased risk for NTDs (Ray, 2003). A tripling in the risk for NTDs in the presence of 
low maternal vitamin B12 status, has been explored (Ray etal , 2007). 
An association between the presence of NTDs and low level of serum zinc levels of 
mothers after delivery has been reported (Golalipour etal., 2009). An association between 
presence of NTDs and low zinc levels among newborns also has been found (Carrillo –
Ponce, etal., 2004). 
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2.3.4. Epidemiology of NTDs 
 
Geographic and temporal variation in the prevalence of anencephaly and spina bifida is 
well documented. In California, the prevalence of NTDs was reported to be highest in 
Hispanics (1.12 per 1,000), lowest in Blacks and Asians (0.75 per 1,000), and 
intermediate in non-Hispanic Caucasian (0.96 per 1,000) (Mittchell ,2005). 
Anencephaly and spina bifida occur at frequencies ranging from 0.9 in Canada to 7.7 in 
the United Arab Emirates and 0.7 in central France to 11.7 in South America per 1,000 
births ( Detrait etal. 2005). 
Gu and colleagues reported the overall NTDs rate for the 3 year study period equal to 
199.38 per 10,000 pregnancies in Shanxi province in China (Gu, etal., 2007). In the 
United Kingdom and Ireland, yearly prevalence of NTDs has been 45 per 10 000 births 
before any preconception folic acid supplementation policy initiatives, and declined to 10 
to 15 per 10 000 in the 1990s. In the rest of Europe the prevalence during the 1980s and 
thereafter was close to 10 per 10 000 births (Busby 2005). 
In Australia, the prevalence of NTDs among births of 4.6 per 10,000 was reported 
(Abeywardana 2008). The Australian researchers showed that teenage women had the 
highest rate and women aged 30–34 years the lowest. The rate of pregnancies affected 
with NTDs was higher for women living in remote areas than for women living in major 
cities. Multiple pregnancies were more likely to have NTDs than singleton pregnancies ( 
Abeywardana 2008). 
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2.4. Food fortification 
 
The term “food fortification” refers to the addition of one or more essential nutrients to a 
food, regardless of whether they occur naturally in the food. The purpose of fortification 
is to correct a recognized population-wide micronutrient deficiency or to add 
micronutrients lost in processing back to their original levels (restoration) or even higher. 
In many situations, this strategy can lead to relatively rapid improvements in the 
micronutrient status of a population, and at a very reasonable cost, especially if advantage 
can be taken of existing technology and local distribution networks. Since the benefits are 
potentially large, food fortification can be a very cost-effective public health intervention. 
However, an obvious requirement is that the fortified food needs to be consumed in 
adequate amounts by a large proportion of the target population. It is also necessary to 
use food vehicles that are centrally processed. Food fortification reinforces and supports 
ongoing nutrition improvement programmes and should be regarded as part of a broader, 
integrated approach to improve micronutrient status at the population level. 
2.4.1 Rational for folic acid fortification 
A Peri-conceptional increase in the intake of folic acid by women of childbearing age 
reduces the risk of having an infant with a neural tube defects (Ray 2004).Many countries 
are considering folic acid fortification to ensure sufficient intake of folic acid for women 
of childbearing age, because many women who plan their pregnancies do not take folic 
acid supplements in the advised period and many other pregnancies are unplanned. 
Food fortification with folic acid as the intervention seems likely to succeed in increasing 
folate intake among populations throughout the world, especially in less-developed 
countries. Dietary changes and prophylactic supplementation appear as unfeasible 
strategies in these countries, due to the lack of means for educational campaigns, lack of 
compliance, and the fact that most pregnancies are not planed. 
 
2.4.2. Experiences of folic acid fortification 
About 75% of the folate in whole wheat is lost during milling, but folic acid has been 
included in cereal fortification programmes only relatively recently. In 1998, it became 
mandatory to fortify grain products with folic acid in the United States, the rationale 
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being that it would lower the prevalence of neural tube defect births. The required 
fortification level is 154µg/100 g flour. In addition to the United States, some 30 
countries now add folic acid to flour, including Canada (150µg/100 g), Chile 
(220µg/100g wheat flour), Costa Rica (180µg/100 g), Dominican Republic (180µg/100 
g), El Salvador (180µg/100 g), Guatemala (180µg/100g), Honduras (180µg/100g), 
Indonesia (200µg/100g wheat flour), Mexico (200µg/100g wheat flour), Nicaragua 
(180µg/100 g) and  Panama (180µg/100 g) (Allen, etal,2006). 
2.4.3. Stability 
Folic acid is added in the form of petroylmonoglutamic acid that is moderately stable to 
heat. There is some loss of the vitamin on exposure to light, and during cooking and 
baking. The biggest loose tend to occur from biscuits and pasta, but even these are 
probably no more than 20-30% (Allen, etal, 2006). 
2.4.4. Safety of flour fortification with folic acid    
The consumption of folic acid in amounts normally found in fortified foods has not been 
associated with adverse health effects. However, there has been some concern that high 
folic acid intakes could mask or exacerbate neurological problems, such as pernicious 
anaemia, in people with low intakes of vitamin B12 .This has led to reluctance to fortify 
with folic acid in some countries. This concern is particularly pertinent to those 
individuals who derive folic acid from both supplements and a range of fortified foods, as 
it is the case in many industrialized countries. In this situation, some people may exceed 
the UL for folic acid, which has been set at 1000μ g /day (National Academi of Scineces, 
2000). To avoid any possible risk of adverse effects, folic acid fortification programmes 
should be designed so as to limit regular daily intakes to a maximum of 1mg (Allen, etal., 
2006).  
2.4.5. Flour fortification in Iran 
Mandatory flour fortifiation with iron and folic acid has been implemented from 2005 
and expanded simoltanusly.There is evidence on the magnitude of iron deficiency and 
anemia among different age groups in Iran that shows the nesssisity of adding iron to 
wheat flour.  For adding folic acid to flour , although, there is not any large scale study on 
folic status in Iran, considering the importance of folic acid in health and available 
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experience on fortification with folic acid, the National scientific Committee of flour 
fortification in the Ministry of Health and Medical Education approved  to fortified wheat  
flour with folic acid  simultaneously with iron. 
The premix that is used for fortifying wheat flour is consisted of 30 PPM iron in the form 
of ferrous sulfate and 1.5 ppm folic acid that should be added to the flour in proper 
proportion (200 gr per each ton of flour).  
It is pretended that this amount of added folic acid to wheat flour obtain 150 μg folic acid 
per 100 g wheat flour. 
 
2.4.6. Quality Control of fortified flour in Iran 
  
2.4.6.1. Semi quantitative test  
 
Semi quantitative test is being used at the mills level to control the fortified flour. Semi 
quantitative test or spot test ( AACC method 40-40 , Iron- Qualitative method) is 
universally used in the mills to check whether flour were properly fortified (Nalubola and 
Nestel ,2000) . This test is the identification of ferrous sulfate by using thiosinate and 3% 
hydrogen peroxide solutions which is inexpensive and easy to teach to the laboratory 
technicians of the flour factories due its simplicity. Semi quantitative test give a rough 
indication of the level of  an added Iron. The appearance of red-colored spots indicates 
the presence of Iron. The number of spots is a rough estimate of the amount and 
homogeneity of Iron in the sample. For a more accurate estimation , test samples are 
compared with known concentrations of Iron ( 30,60 and 90  ppm). At least one spot test 
has to be done per 8 hr. shift of the mill . 
 
2.4.6.2. Quantitative test 
Quantitative test is being used by applying the spectrophotometric method to measure the 
amounts of iron in fortified flour in the Provincial Food Laboratory. Once a week ,during 
the visit of the mills, 2 random sample of fortified flour which have already been tested 
by the spot test  in the factory is collected and noted down  their  properties on a label and 
is sent  along with the sample to the Provincial Food Laboratory .In the Provincial 
Laboratory , the proportion of iron in the sample is determined by spectorophotometric 
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method (Nalubola and Nestel ,2000)  and finally the amount of iron is determined on ppm 
bases. In case the amount of iron is not acceptable, the problem is announced to the 
factory by phone and the Province’s Health center is also informed. 
2.4.6.3. Indicator nutrient 
 The use of a single nutrient in flour as an index of all the micronutrients added by a 
fortification premix has been advised. Given that the indicator nutrient is within 
specification, it follows that all the other micronutrients should be as well providing that 
the fortification premix is correct. Iron is the most likely nutrient to be used as an 
indicator of adequate fortification in government control (Johnson etal., 2004).  
Analysis of folate is not easy due to its multiple forms, lower stability, presence in lower 
concentration in biological systems, and complex extraction and detection techniques. 
Because of the difficulty and high cost of measuring the amount of folic acid in fortified 
flour in a routine way, it is decided to monitor iron as an indicator nutrient in the flour 
fortification program in Iran.  
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3. Methodology 
 
3. 1.  Study location 
 
This study was conducted before and after mandatory flour fortification with iron and 
folic acid in the Golestan province located in the north of Iran. Golestan province has a 
population of about 1.8 million and covers an area of about 20460 kilometer. 
In this province, the dietary pattern is plants based . Per capita supply of energy and 
protein are more than requirement, provide 65, 25, and 11% of total energy from 
carbohydrate, fat and protein, respectively. Cereals (bread and rice) are the main staple 
foods. 
3.2. Study design  
This evaluative study was designed as a population based study and included three 
components as follow: 
1. A longitudinal hospital based study was conducted 12 months before and 12 
months after flour fortification to determine the trend of NTDs . 
2. A cross sectional survey was carried out in the pre-fortification period (2006). 
Biochemical indicators of folate status, socio - demographic, health characteristics 
and dietary intake were studied as base line data in 580 women of child bearing 
age as representative sample of Golestan Province. 
3. A cross sectional survey was carried out in the post- fortification period (2008). 
Biochemical indicators of folate status, socio demographic, health characteristics 
and dietary intake were studied in 600 women of child bearing age and compared 
to the results of baseline data. 
3.3. Sample size 
Sample size calculation is based on the study, before and after intervention. The sample 
size was 580 women at base line and was rounded up to 600 in the final survey . 
This sample size was chosen according to the following formula 
α =% 5 z 1- α = 1.65 (one sided)         ß = % 20 z 1- ß = 0.84 
p0 = % 13 p1 = % 8                            p = (p0 + p1) / 2 
n= [2 * (z1- α + z 1- ß)                     2 * p* (1-P)] / (p0 – p1)2 
Design effect = 1.25                           N= n * Design effect                       N=580 
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3. 4. Variables 
 
The dependent variables were including low serum folate level, low serum vitamin B12 
level, high plasma homocysteine level , high MVC level , as well as mean of serum 
folate, mean of serum vitamin B12, mean of homocysteine level , mean of MCV level 
and prevalence rate of NTDs. As an independent variables, we collected data regarding 
the characteristics considered to be potential confounding variables. These were included 
age, level of education, residency (urban / rural), job, household size, history for stomach 
and intestine surgery, smoking, passive smoking,  husband’s job and marriage status. 
 
3.5. Study criteria 
We included all healthy women aged 15-49 years from urban and rural areas. 
We excluded women from participation if they were pregnant or consuming supplements 
containing folic acid with in the past one month or taking medication known to interfere 
with folate and vitamin B12 metabolism or had a history of chronic disease. 
 
3.6. Sampling technique 
 
Since the aim of this study was not to assess the variables separately in urban and rural 
areas, the sample size estimated for Golestan Province was only proportioned in the 
districts of the province. 
Then according to the sampling frame in rural and urban areas, main cluster households 
were selected. In each cluster 10 women aged 15 to 49years were studied. 
There was a gap of at least one household between the two women in each cluster and  
if there was not a woman in this household, the nearest house was selected to find a 
woman in this age group. In each selected household only one women 15-49 years old 
was studied (The fist woman who the interviewer contacted her in the household).The 
sampling frame in each urban area was the list of households from the latest census. 
The sampling frame in each rural area was the latest list of households prepared by 
Provincial Health Center. Distribution of the clusters is shown in table 1. 
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Table 1: Distribution of the clusters by districts in Golestan province 
 
 
District 
 
Total 
population* 
Total 
number 
of 
clusters 
 
Urban 
population†
Number 
of 
urban 
clusters 
 
Rural 
population∞ 
Number 
of rural 
clusters 
Kalale 45333 5 10504 1 34829 4 
Minoodasht 39308 5 14656 2 24652 3 
Gonbad 88196 11 40795 5 47401 6 
Azadshahr 27479 3 15360 2 12119 1 
Ramian 24809 3 9390 1 15419 2 
Aliabad 38489 5 18638 2 19851 3 
Aqqala 33547 4 10178 1 23396 3 
Gorgan 126259 15 90447 11 35812 4 
Bandar-
Torkaman 
36735 5 22342 3 14393 2 
Kordkoy 20833 2 9169 1 11664 1 
Bandar-
Gaz 
14229 2 8081 1 6148 1 
Total 495244 60 249560 30 245658 30 
* Total population of women 15-49 years  in Golestan province 
† Population of women 15-49 yeas in urban areas 
∞ Population of women 15-49 yeas in rural areas 
 
3.7. Data collection technique 
 
3.7.1. Socio-demographic data gathering 
At the beginning of interview, the selected woman was provided with explanations about 
the study. After getting the written consent, the interview was conducted and then she 
was invited for the next morning to come in the rural or urban health center which was 
selected for collecting of blood samples. Interviews were conducted in a private place. 
 38
All the women were advised to be overnight fasting (at least 12 hours) for taking blood 
samples. Investigation teams started work at 8 to 8:30 AM, so that the interval between 
the first blood sampling and its transfer to the laboratory had to be no more than 3 hours. 
Each day, after the end of blood sampling procedure, samples were placed in cold boxes 
and transferred to the provincial laboratory. 
 
3.7.2. Dietary assessment  
 
Diet was assessed by a single 24-h-recall. Trained nutritionists from the Provincial Health 
Center interviewed each subject individually about their food and beverage intake of the 
previous day, processed food items (if known), and the type and names of manufacturers. 
The field work covered all days of the week, including weekends. The portion sizes were 
described in household measures and for processed food items by using the 
manufacturer’s information.  
Three nutrition officers from the Ministry of Health supervised the study at the field 
level. The diet records were coded by one of the principal investigators using an Iranian 
food composition database (Dorosty , 2003 ), modified, using the new version of the UK 
food composition tables ( Maccance and Widdowson,s 2004) for the folate contents of 
those food items which were not included in the Iranian food composition software. The 
final dietary intake data were validated in the Department of Nutritional Sciences, 
University of Vienna, Austria, by comparing the nutrient content of selected food items, 
representative of the average Iranian diet, with the food composition data of the Austrian 
food composition database. The selected 42 food items included major food sources of 
folate (i.e. green leafy vegetables, fruits, pulses, cereals, dairy/egg products, and 
nuts/seeds). The observed variation in the nutrient content was mostly 10-15% for 27 of 
them such as vegetables, fruits, dairy products, and bread. In some kinds of pluses (i.e. 
lentils and beans), the observed variation was up to 30%, but within the expected limits. 
 
3.7.3. Blood sample collection 
From each woman, about 10 ml over night fasting blood sample were collected. Before 
testing the blood samples , the cell counter in the provincial laboratory was calibrated and 
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the laboratory technicians were trained by the technical expert of the National Reference  
Laboratory . 
To measure serum concentrations of folate and vitamin B12, 5 ml of blood sample were 
collected in a test tube, transferred to the Province Laboratory in cold boxes, and 
centrifuged (2000 RPM for 15 minutes) immediately. 
For homocysteine determination in plasma, 2 ml of blood samples were collected in a test 
tube which contained 50 μL of EDTA. Those samples collected in rural areas were 
immediately centrifuged by using a mobile centrifuge (1700 RPM for 15 minutes) and 
transferred in cold boxes to the Province Laboratory, while the other blood samples were 
centrifuged in the Provincial Laboratory. Test tubes containing plasma were stored at -20 
ºC and transferred to the National Reference Laboratory in Tehran to measure folate, 
vitamin B12, and homocysteine concentrations.  
    For testing Complete Blood Count ( CBC), 2 milliliter of whole blood was put in covered 
tubes contains 50 micro liters of EDTA and thoroughly stirred. These were transferred as 
fast as possible (in 3 hours’ time) to the provincial laboratory.  
3.7.4. Bread sample collection 
 
   Samples of bread were collected during the final evaluation in 2008.   
Bread samples were collected at the household level and during interview with the 
random selected woman. One sample of bread was collected from the home of the first 
women in each cluster, totally 60 bread samples were gathered from 60 selected clusters. 
Bread samples were collected during the final evaluation that was expected to be fortified 
with folic acid. 
 
3.7.5. NTD data gathering technique 
 
Since the Iranian Primary Health Care system does not have a national birth defect 
registry, we established a hospital – based surveillance system to register NTDs.  
This  is a referral hospital with an annual rate of around 6500 deliveries, accounting for 
25% of annual birth in Golestan province and the largest portion of deliveries (80%) in 
Gorgan district (capital city). Patients are usually from moderate to low socioeconomic 
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class families. In this hospital, two members of the staff (registered nurse) have been 
recruited and trained to revise all births, to register and to describe NTD. Types of NTD 
registered were anencephaly, encephalocele, and spina bifida associated or not with other 
malformations. If two neural tube defects in a newborn occur concomitantly, the 
anatomically higher defect was recorded. A specially trained clinical geneticist monitored 
the correct registration of NTD. 
Rate of NTDs was defined as the number of NTDs cases, divided by the total number of 
live births, stillbirths, and pregnancy terminations for an NTDs. Total prevalence rates 
were calculated as a total number of NTD per 1000 births. Time trend analysis of 
monthly NTD rates was performed. 
We included all live births and stillbirths (a gestational age of ≥20 weeks and ≥500 g who 
were admitted in neonatal intensive care unit (NICU) of Dezyani teaching hospital, from 
September 2006 (before flour fortification) to December 2008 (after flour fortification).  
We defined NTDs according to the International Classification of Diseases (ICD, 2007). 
The design was based on a sample of 13361 postpartum women after admission for 
childbirth in Deziani hospital which is a referral center for obstetrics and gynecologic 
problems. Data were collected through interviews with mothers in the immediate 
postpartum, as well as by reviewing the patient records of both the mothers and newborn 
infants. The clinical notes of the babies and their mothers were reviewed, and the 
following data were recorded; antenatal diagnosis and care, age, level of education, usage 
of folic acid supplement, smoking and type of the NTD. 
3.8. Analytical methods 
3.8.1. Biochemical tests 
 The Complete Blood Count (CBC) was performed using a KX-21N (Sysmex) cell 
counter, in order to obtain MCV measure. A control solution (Labex) was used as a blood 
reference, and device and quality control checks were performed before and after daily 
analysis of the collected blood samples.  
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Folate and vitamin B12 levels were measured using the SimulTRAC-SNB Radioassay 
Kit vitamin B12 / Folate and the results were validated by the National Reference 
Laboratory. The same method for measuring serum folate and vitamin B12 was used in 
both before and after studies. 
Determination of homocysteine concentration in overnight fasting blood plasma was 
made by High Performance Liquid Chromatography and fluorescence detection (Ubbink 
et al., 1991). 
Reference values of Sauberlich were used to define lower limits of adequate serum 
concentrations of folate and vitamin B12, i.e. for folate <6.7 nmol/L and for vitamin B12 
<110 pmol/L (Sauberlich 1999). An elevated plasma homocysteine concentration was 
defined as >12 μmol/L (moderate hyperhomocysteinemia) (Stanger etal., 2003). The 
recommended dietary allowance (RDA) of 2.4 μg for vitamin B12 and 400 μg for food 
folate were used to define adequacy of intakes (National Academy of Sciences, 2000). 
3.8.2. Bread testing g method 
 
Reversed – phase ion –pair high – performance liquid chromatography ( HPLC) was 
coupled with detection by UV absorption ( 280nm) for separation and quantitation of 
added folic acid in fortified beard ( Ossey eatl,1998). 
3.9. Statistical Analysis of Data 
 
Collected data on NTDs were analyzed by STATA version 10 and were compared with 
the chi-square test. The rate ratio (RR) and 95% CI was estimated for effect of 
fortification. A P-value of 0.05 or less was considered statistically significant. 
SPSS for Windows (Version 13) was used for all statistical procedures of socio-
demographic, blood tests and measures of folic acid in the beard samples and intake data. 
Summaries of numerical variables were presented as mean, standard deviation (SD), and 
95% confidence interval (95% CI). Changes in hematological indices and intake data 
from base line before and after flour fortification were assessed using t- test. 
Logistic and linear regression (for numeric variables) was used to adjust for confounders. 
Statistical significance was set at p<0.05.  
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4. Results 
 
4.1. Socio-demographic characteristics  
4.1.1. Completeness of data 
 At baseline (pre-fortification period), the total number of samples assessed was 579. One 
participant was excluded because of uncompleted questionnaire. The final numbers 
analyzed for different types of variables were as follow: women for dietary assessment, 
557 (22 subjects were excluded due to incompleteness of dietary data); serum samples for 
folate and vitamin B12, 572 (7 samples were excluded due to clotting); plasma samples 
for homocysteine, 561 (18 samples excluded due to clotting).  
At the post –fortification period we rounded up the sample to 600 women. We analyzed 
the results of 600 blood samples for serum folate, serum B12 and plasma homocysteine. 
Dietary intake data was analyzed for 594completed questionnaires.  
4.1.2. Subjects  
We compared the socio-demographic characteristics of the studied women in order to 
find whether there are significant differences between the characteristics of the studied 
women in the pre-fortification and post-fortification period. 
As table 2 shows the proportion of the studied women in rural and urban areas was not 
significantly different at baseline and final study (p= 0.907).  
Table 2: Distribution of the studied women by residence before and after flour  
fortification  
 
Residence Pre-fortification 
Period * 
Post –fortification 
Period† 
Total P 
value 
Urban 
Number 
% 
 
292 
49.3 
 
300 
50.7 
 
592 
100 
Rural 
Number 
% 
 
287 
48.9 
 
300 
51.1 
 
587 
100 
Total 
Number 
% 
 
579 
100 
 
600 
100 
 
1179 
100 
 
 
 
0.907 
*December 2006   
† December 2008 
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Table 3 shows that the distribution of the studied women by district was not significantly 
different at baseline and post-fortification period (P = 0.847). 
Table 3: Distribution of the studied women by district before and after flour 
fortification  
 
      *December 2006             † December 2008 
District Pre-fortification 
Period * 
Post –fortification 
Period† 
Total 
Kalaleh 
Number 
% 
 
47 
8.1 
 
60 
10 
 
107 
9.1 
Minodasht 
Number 
% 
 
50 
8.6 
 
40 
6.7 
 
90 
7.6 
Gonbad 
Number 
% 
 
99 
17.1 
 
110 
18.3 
 
209 
17.7 
Azadshahr 
Number 
% 
 
40 
6.9 
 
30 
5 
 
70 
5.9 
Ramian 
Number 
% 
 
30 
5.2 
 
30 
5 
 
60 
5.1 
Aliabad 
Number 
% 
 
40 
6.9 
 
50 
8.3 
 
90 
7.6 
Aghghala 
Number 
% 
 
40 
6.9 
 
40 
6.7 
 
80 
6.8 
Gorgan 
Number 
% 
 
143 
24.7 
 
150 
25 
 
293 
24.9 
Bandartorkaman 
Number 
% 
 
50 
8.6 
 
50 
8.3 
 
100 
8.5 
Kordkoy 
Number 
% 
 
20 
3.5 
 
20 
3.3 
 
40 
3.4 
Bandargaz 
Number 
% 
 
20 
3.5 
 
20 
3.3 
 
40 
3.4 
Total 
Number 
% 
 
579 
100 
 
600 
100 
 
1179 
100 
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Table4: Distribution of the studied women by education level before and after flour 
fortification  
 
Education Pre-fortification
Period * 
Post –fortification
Period† 
Total 
Illiterate 
Number 
 
% 
 
58 
 
10.1 
 
80 
 
13.3 
 
138 
 
11.7 
Primary level 
Number 
 
% 
 
207 
 
35.9 
 
214 
 
35.7 
 
421 
 
35.8 
Secondary level 
Number 
 
% 
 
135 
 
23.4 
 
124 
 
20.7 
 
259 
 
22 
Diploma 
Number 
 
% 
 
136 
 
23.6 
 
137 
 
22.8 
 
273 
 
23.2 
University degree 
Number 
 
% 
 
41 
 
7.1 
 
45 
 
7.5 
 
86 
 
7.3 
Total 
Number 
 
% 
 
577 
 
100 
 
600 
 
100 
 
1177 
 
100 
 
      *December 2006   
      † December 2008 
 
Table 4 shows that the education level of the studied women was not significantly 
different at baseline and post-fortification period (P = 0.429). 
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Table 5: Distribution of the studied women by job status before and after flour 
fortification  
 
Job status Pre-fortification
Period * 
Post –fortification
Period† 
Total 
Housewife 
Number 
 
% 
 
477 
 
82.4 
 
511 
 
85.2 
 
988 
 
83.8 
Employed in home 
Number 
 
% 
 
34 
 
5.9 
 
35 
 
5.8 
 
69 
 
5.9 
Employed out of home 
Number 
 
% 
 
36 
 
6.2 
 
36 
 
6 
 
72 
 
6.1 
Student 
Number 
 
% 
 
32 
 
5.5 
 
18 
 
3 
 
50 
 
4.2 
Total 
Number 
 
% 
 
579 
 
100 
 
600 
 
100 
 
1179 
 
100 
*December 2006   
† December 2008 
 
 
From the results presented in table 5, it can be observed that there was not a significant 
difference between distribution of women by job status in the pre –fortification and post-
fortification period (P = 0.193). 
 
Table 6 shows the distribution of the women by age groups. A significant difference 
between age distribution of the studied women at base line (before fortification) and final 
evaluation (after fortification) was not found (p = 474). 
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Table 6: Distribution of the studied women by age groups, before and after flour 
fortification 
 
Pre-fortification 
Period * 
 
Post-fortification 
Period† 
 
  
Age(year) 
     N 
 
% n % n % 
 
 
P value 
15-20  72 
 
12.4 69 11.5 141 12 
21-30   
 
212 36.6 201 33.5 413 35 
31-40  180 
 
31.1 211 35.2 391 33.2 
>40 115 
 
19.9 119 19.8 234 19.8 
Total 579 
 
100 600 100 1179 100 
    
 
0.474 
*December 2006   
† December 2008 
 
 
Comparing the other confounding variables ( table 7) showed that there were not 
significant difference between  distribution of the studied women by the mean of age ( p 
= 0.129), smoking ( P = 0.147), passive smoking ( p = 0.396), history of stomach surgery  
( P =  0.474), contraceptive using ( P = 0.336) and lactation ( P = 0.323) and marriage 
status ( p = 0. 614).In contrast ,there were significant difference at baseline and after flour 
fortification in the household’s size ( p = 0.000), and husband’s job ( % of unemployed )  
( p =  0.02) . 
 
In the logistic regression model, all biochemical indicators including serum folate, serum 
vitamin B12 and plasma homocysteine (Hcy) were adjusted for those socio-demographic 
characteristics of the studied women that were found to be significant. 
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Table 7: Other characteristics of the studied women before  and after flour 
fortification  
 
Variable Pre- fortification 
Period* 
Post- fortification 
Period† 
 
P value 
Mean age ±SD( year) 
 
 
31.4±9.1 32.2±8.9 0.129 
Smoking  
7 ( 1.2) 
 
 
13(2.2) 
 
 
0.261 
Passive smoking 
 
 
145 (25) 
 
 
136 (22.7) 
 
 
0.396 
History of gastric 
surgery 
 
 
7(1.2) 
 
 
6(1.0) 
 
 
0.786 
Contraceptive 
 
 
109(22.8) 
 
 
126(24.1) 
 
 
0.336 
Lactation 
 
 
84(17.5) 
 
 
85(16.3) 
 
 
0.613 
Household’s size 
(mean ±SD) 
 
 
4.89 ±1.9 
 
4.51±1.6 
 
0.000 
Husband’s job 
(Unemployed) 
 
 
62(10.7) 
 
 
92(13.1) 
 
 
0.020 
 
Married 
 
 
477(82.4) 
 
 
499(83.6) 
 
 
0.614 
*December 2006   
† December 2008 
Figures in brackets are percentage 
Total number of women in pre-fortification period = 579 
Total number of women in pre-fortification period = 600 
 
4.2. Biochemical indicators of folate status 
 
Table 8 shows the mean (CI 95%) for serum folate and plasma homocysteine 
concentrations in the studied women at base line and after flour fortification with folic 
acid. As this table shows, the mean serum folate concentration significantly increased 
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from 13.6 nmol/L to 18.1 nmol/ L, after the initiation of flour fortification with folic acid 
( p = 0.000) . Also, the mean plasma Homocysteine concentrations significantly declined 
from 12.6 μmol/L to 7.1 μmol/L after flour fortification (p = 0.000).  
Table 8: Serum Folate and plasma homocysteine concentrations of the studied 
women before and after fortification 
 
95% Confidence 
Interval 
 
Indices 
 
   n 
 
Mean Lower 
Bound 
Upper 
Bound 
2.5 
percentile 
97.5 
percentile 
 
P 
value 
Serum folate 
(nmol/L) 
 
Pre-fortification 
period * 
 
Post-fortification 
Period† 
 
Total 
 
 
 
572 
 
 
600 
 
1172 
 
 
 
 
 
13.6 
 
 
18.1 
 
15.9 
 
 
 
12.8 
 
 
17.4 
 
15.4 
 
 
 
14.3 
 
 
18.8 
 
16.4 
 
 
 
4.1 
 
 
6.8 
 
4.7 
 
 
 
36.6 
 
 
39 
 
37.2 
 
 
 
 
0.000 
Hcys (μ mol/L)∞ 
 
Pre-fortification 
Period * 
 
Post-fortification 
Period† 
 
Total 
 
 
 
561 
 
 
600 
 
1161 
 
 
12.6 
 
 
7.1 
 
9.8 
 
 
12.1 
 
 
6.7 
 
12.8 
 
 
13.2 
 
 
7.5 
 
10.2 
 
 
5.5 
 
 
2.8 
 
3 
 
 
32.6 
 
 
21.7 
 
28.1 
 
 
 
0.000 
 
*December 2006 
†December 2008 
∞ Homocysteine concentrations 
 
From the results presented in table 9, it can be observed that low serum folate has 
decreased significantly form 14.3% at baseline to 2.3 % after flour fortification 
(p=0.000).  
Also, a significant reduction in the prevalence of hyperhomocysteinemia, from 38.3% in 
the pre-fortification period to 7.3% in the post – fortification period was found.  
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Table 9: Prevalence rate of low serum folate and hyperhomocysteinemia before and 
after flour fortification 
 
 
Pre-
fortification 
Period * 
 
Post-fortification 
Period† 
 
Total  
 
 
Indices 
n % n %    n % 
 
 
 
 
P value 
Folate (nmol/L) 
 
     Normal 
 
     Low 
 
    Total 
 
 
 
490 
 
82 
 
572 
 
 
85.7 
 
14.3 
 
100 
 
 
584 
 
14 
 
600 
 
 
97.7 
 
2.3 
 
100 
 
 
1076 
 
96 
 
1172 
 
 
91.8 
 
 
8.2 
 
100 
 
 
 
0.000 
Hcys (μ mol/L)∞ 
 
    Normal 
 
    High 
   
   Total 
 
 
346 
 
215 
 
561 
 
 
61.7 
 
38.3 
 
100 
 
 
556 
 
44 
 
600 
 
 
92.7 
 
7.3 
 
100 
 
 
902 
 
259 
 
1161 
 
 
77.7 
 
22.3 
 
100 
 
 
 
 
0.000 
 
 
 
 
*December 2006 
†December 2008 
∞Homocysteine concentrations 
 
Figure1 shows the distribution curves of serum folate concentrations before and after 
fortification. This figure shows the clear upward shift in the distribution of serum folate 
from baseline (before fortification in 2006) to the final evaluation (after fortification in 
2008).  
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Figure 1: Decline in the prevalence of low serum folate after flour fortification with folic acid in 
the studied women (vertical line shows serum folate<6.7 nmol/L) . 
 
 
From the results present in the table 9, it can be observed that a significant reduction in 
the prevalence of hyperhomocysteinemia has been achieved, that is from 38.3% to 7.3%  
( P=0.000) in the pre- and post -fortification period respectively. 
Figure 2 shows the distribution curves of plasma Hcy concentrations in the pre-
fortification and post-fortification period. This figure shows a clear downward shift in the 
distribution of plasma Hcy concentrations from baseline to the final evaluation. 
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 Figure 2: Decline in the prevalence of hyperhomocysteinemia after flour fortification with folic 
acid among the studied women (vertical line shows Hcy>12μmol/ L). 
 
The distributions of the women by serum folate and plasma homocystein concentrations, 
before and after flour fortification are shown in figure 3. 
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Figure 3: Distribution of the studied women by serum folate and plasma Homocysteine before 
and after flour fortification 
 
Figure 4 shows that there was a significant negative correlation between serum folate and 
plasma homocysteine concentrations in the pre-fortification period ( r = -0.252 , P ,0.01) 
and post- fortification period ( r = -0.171 ; p = 0.000). 
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Figure 4: correlation between serum folate and Homocysteine before and after flour 
fortification with folic acid 
 
Figure 5 shows that There was a significant negative correlation between serum vitamin 
B12 levels and plasma homocysteine concentrations in the pre-fortification ( r = -0.213 , 
P<,0.01) and post- fortification period ( r = -0.208 ; p = 0.000). 
Our results show that after flour fortification with folic acid ,  homocysteine correlated 
better with serum vitamin B12 levels ( r = - 0.208 ; p = 0.000) than with serum folate 
levels ( r = - 0.171, p = 0.000  ).  
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Figure 5: Correlation between Homocysteine and serum vitamin B12, before and after flour 
fortification with folic acid 
 
As figure 6 shows, we observed a direct association between serum vitamin B12 and 
serum folate before flour fortification ( r = 0.322 ,p = 0.01), and after flour fortification  
(r = 0.093, p = 0.05) .  
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Figure 6: correlation between serum folate and vitamin B12 before and after flour fortification 
with foilc acid 
 
From the results presented in table 10 , it can be observed that the mean serum folate was 
11.3 nmol/L ( 95% CI 10.3-12.4 nmol/L ) and 17.3 nmol/L ( 95%CI 16.1-18.5 nmol/L) 
for women classified as having a low serum Vitamin B12 , in the pre-fortification and 
post-fortification periods respectively . Among the women classified as having a normal 
serum Vitamin B12, the mean serum folate were 14.3 nmol/L ( 95% CI: 13.3-15.2nmol/L 
) and 18.5 nmol/L( CI95% 17.8-19.3nmol/L), in the pre-fortification and post-
fortification periods respectively . 
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Table 10: Serum folate status in the studied women according to serum vitamin B12 
status , before and after flour fortification 
 
95% Confidence 
Interval 
 
Serum 
vitamin B12₪ 
 
 
n 
 
serum folate 
∞ Lower Bound Upper Bound 
 
Minimum
 
Maximum 
 
P 
value 
Low 
Pre-
fortification 
Period * 
 
Post-
fortification 
 Period † 
Total 
 
 
 
 
130 
 
 
205 
 
335 
 
 
 
11.3 
 
 
17.3 
 
15 
 
 
 
10.3 
 
 
16.1 
 
14.1 
 
 
 
12.4 
 
 
18.5 
 
15.9 
 
 
 
2 
 
 
5.9 
 
2 
 
 
 
40.6 
 
 
67.7 
 
67.7 
 
 
 
0.000 
Normal 
Pre-
fortification 
Period * 
Post-
fortification 
Period † 
Total 
 
 
 
442 
 
395 
 
837 
 
 
14.3 
 
18.5 
 
16.3 
 
 
13.3 
 
17.8 
 
15.6 
 
 
15.2 
 
19.3 
 
16.9 
 
 
2.2 
 
5 
 
2.2 
 
 
86.5 
 
51.4 
 
86.5 
 
 
0.000 
*December 2006 
†December 2008 
∞ Mean serum folate ( nmol/L) 
₪ Pmol / L 
 
 
From the results presented in table 11, it can be observed that the mean serum vitamin 
B12 of the studied women has declined significantly in the post –fortification period  
(p = 0.000). 
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Table11:  Serum vitamin B12 status of the studied women, before and after flour 
fortification 
95% Confidence 
Interval 
 
Serum vitamin 
B12 (pmol/L) 
 
 
n 
 
Mean 
Lower 
Bound 
Upper 
Bound 
 
2.5 
percentile 
 
97.5 
percentile 
 
P value 
 
Pre-fortification 
Period * 
 
Post-fortification 
Period† 
 
Total 
 
 
 
572 
 
600 
 
1172 
 
 
194.4 
 
163.5 
 
178.6 
 
 
183.8 
 
153.4 
 
1712 
 
 
205 
 
173.6 
 
186 
 
 
48 
 
17.6 
 
22.7 
 
 
 
490.8 
 
413 
 
453.1 
 
 
 
0.000 
*December 2006 
†December 2008 
 
The results of our study showed that the mean serum vitamin B12 significantly decreased 
by 30.9 Pmol/l , that is from 194.4 Pmol/L to 163.5 Pmol/L. As table 12 shows ,the 
percentage of low serum vitamin B12 among the studied women significantly increased 
from  22.7  % before flour fortification to 34.2 % after flour fortification with foilc acid ( 
p = 0.000).  
Table 12: Prevalence rate of low serum vitamin B12 in the studied women , before 
and after flour fortification 
 
Pre-fortification Period 
* 
 
Post-fortification 
Period† 
 
 
Serum vitamin B12 
(Pmol/L) 
  
n 
 
 
% 
 
n 
 
 
% 
 
P 
value 
 
Normal 
 
Low 
 
Total 
 
442 
 
130 
 
572 
 
 
77.3 
 
22.7 
 
100 
 
395 
 
205 
 
600 
 
65.8 
 
34.2 
 
100 
 
 
0.000 
*December 2006 
†December 2008 
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In order to assess the possibility of masking vitamin B12 deficiency, we investigated 
whether or not the proportion of the studied women with low serum vitamin B12 
concentrations without macrocytosis has increased in the post – folic acid fortification 
period.  
 
Table 13 presents the association between the proportion of women with low serum 
vitamin B12 concentrations (<110 Pmol/L) without macrocytosis (MCV>96fl).The 
proportion of women without macrocytosis was higher after flour fortification (82.9%) 
than before flour fortification (80%), and the difference was not significant (p = 0.370). 
 
Table 13: Distribution of MCV in the studied women with low serum vitamin B12, 
befor and after flour fortification 
 
 
              Serum vitamin B12 
               Low (<110Pmol/L) 
 
 
 
MCV(fl) 
 
 
Pre- fortification 
Period* 
Post- fortification 
Period† 
 
 
Total 
 
 
P 
value 
Number 104  170  274  
Normal %   80  82.9 81.8 
Number 21 32 53 High∞ 
 % 16.2 15.6 15.8 
Number 130 205 335  
Total % 100 100 100 
 
 
     *December 2006 
     †December 2008 
    ∞ MCV>96fl 
 
From the results present in the table 13, it can be observed that women with a low serum 
vitamin B12 concentration were no more likely to be without anemia after flour 
fortification with folic acid.  
 
Table 14 shows the mean MCV (fl) among the studied women. Overall, mean MCV in 
the post -fortification period (83.5fl) was significantly lower than the mean of MCV  
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(84.3fl)  in the pre-fortification period (p = 0.000).  
Table 14: MCV status of the studied women before and after flour fortification with 
folic acid 
95% Confidence 
Interval 
 
 
MCV(fl) 
 
 
n 
 
 
Mean Lower 
Bound 
Upper 
Bound 
 
2.5 
percentile 
 
97.5 
percentile 
 
P value 
 
Pre-fortification 
Period * 
 
Post-fortification 
Period† 
 
Total 
 
 
572 
 
 
600 
 
1172 
 
84.3 
 
 
83.5 
 
83.9 
 
83.7 
 
 
82.9 
 
83.5 
 
84.8 
 
 
94 
 
84.2 
 
63.8 
 
 
64 
 
63.8 
 
93.7 
 
 
92.6 
 
93.2 
 
 
 
0.000 
   *December 2006 
     †December 2008 
 
 
To determine whether those who had the lowest vitamin B12 concentrations were more 
likely than others to have higher MCV levels, we examined the correlation between 
serum vitamin B12 and MCV. A negative correlation was found between serum vitamin 
B12 and MCV before fortification that was not significant (r = -0.03; p = 0.485). 
However, after flour fortification a significant negative association between MCV and 
serum vitamin B12 was found (r = - 0.139; p<0.01).  
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Figure 7: correlation between serum vitamin B12 and MCV before and after flour 
fortification with folic acid 
 
 
 
4.3. Dietary intake’s Findings 
 
Table 15 shows the mean intake of natural folate before and after flour fortification .The 
mean daily intake of naturally occurring folate for the studied women between pre –
fortification and post- fortification period were 198.3μg/day (95% CI 185.4μg/day -
211.3μg/day) and  200.8μg/day  ( 95%CI 191.9μg/day -209.6μg/day) respectively . A 
significant difference between natural folate intake in the pre-fortification and post- 
fortification period was not found (p = 0.741).  
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Table15: The mean of natural folate intake of the studied women before  and after  
flour fortification 
 
    *December 2006               
   †December 2008 
In the post –fortification period, 6 uncompleted questionnaires were omitted. 
 
Table 16 shows the mean total folate intake of the studied women in the pre-fortification 
period (natural folate) and post- fortification period (natural folate + folic acid added to 
bread). The folate intake of the studied women has increased significantly from 198.3 
μg/day, before flour fortification to 413.7 μg/day after flour fortification ( p= 0.000).  
 
Table 16: The mean of total folate intake in the studied women before and after 
flour fortification 
 
                 
     *∞December 2006 , natural food folate            
     †∞December 2008, natural food folate + folic acid added to bread            
95% Confidence 
Interval 
 
Folate (μg/day) 
 
n 
 
Mean  Lower 
Bound 
Upper 
Bound 
 
2.5 
percentile 
 
97.5 
percentile 
P value 
 
Pre-fortification 
* 
 
Post-fortification 
† 
 
Total 
 
557 
 
594 
 
1151 
 
198.3 
 
200.8 
 
200.3 
 
185.4 
 
191.9 
 
189.1 
 
 
211.3 
 
209.6 
 
210.4 
 
32.4 
 
65.5 
 
49.2 
 
 
 
519.8 
 
461 
 
491 
 
 
 
0.741 
95% Confidence 
Interval 
Folate (μg/day) 
 
n Mean  
Lower 
Bound 
Upper 
Bound 
2.5 
percentile 
97.5 
percentile 
 
P value 
 
Pre-fortification 
*∞ 
 
Post-fortification 
†∞ 
 
Total 
 
 
557 
 
 
594 
 
1151 
 
198.3 
 
 
413.7 
 
309.5 
 
185.4 
 
 
399.2 
 
298 
 
211.3 
 
 
428.1 
 
321 
 
32.4 
 
 
45.4 
 
39.1 
 
519.8 
 
 
794.2 
 
658.1 
 
 
 
 
0.000 
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We assessed the maximum amount of total folate intake after flour fortification. As it can 
be observed in table 16, the percentile of 97.5 for total folate intake was 794.2μg/day . 
We also determined the percentile of 99 for total folate intake, after flour fortification and 
it was 919.5μg/day. 
We assessed the mean consumption of bread in the studied women. From the results 
presented in table 17, it can be observed that the mean ( 95%CI ) of bread consumption 
was 246.2 g/day (234.2 g/day -259.1g/day) in the pre-fortification period, and 253.8g/day 
(242.3 g/day -265.4g/day)in the post-fortification period respectively . There was not a 
significant difference between the amount of bread consumption before and after flour 
fortification (p = 0.821).  
Table 17   : Mean consumption of bread in the studied women before and after flour 
fortification 
 
*December 2006 
   †December 2008 
 
We measured the amount of folic acid in the bread samples that were collected in the post 
–fortification period .Analysis were performed using a high-performance liquid 
chromatography (HPLC) method. The mean folic acid content for 60 bread samples 
collected in the post fortification period, was 89 ±10 μg / 100g of bread (range49 -110 μg 
/ 100g) . Therefore, considering the average amount of bread consumption (253.8 g/day) 
in the post fortification period, the implementation of mandatory flour fortification 
resulted in an average additional dietary intake of 226 μg/day of folic acid from fortified 
95% Confidence 
Interval 
 
Bread ( g/day) 
 
 
n 
 
Mean  Lower 
Bound 
Upper 
Bound 
 
2.5 
percentile 
 
97.5 
percentile 
 
P value 
 
Pre-fortification * 
 
Post-fortification † 
 
Total 
 
 
557 
 
594 
 
1151 
 
246.2 
 
253.8 
 
249.1 
 
234.2 
 
242.3 
 
239.6 
 
259.1 
 
265.4 
 
261.7 
 
51 
 
57 
 
55 
 
615 
 
640 
 
628 
 
 
0.821 
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bread in the studied women. The maximum dietary intake of folic acid due to flour 
fortification was 570μg /day. 
As the figure 8 shows, the percentage of the women having low folate intake  
(< 400μg/day) decreased from 93.8% before flour fortification to 52.9% after flour 
fortification. On the other hand, the percentage of women with folate intake above 
400μg/day increased from 5.6% to 46.8% after flour fortification. Only, 0.3% of the 
studied women in the post-fortification period had a folate intake above 1000μg/day, 
compared to 0.6% of the women in the pre-fortification period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 : Percentage of folate intake (μg/day)among studied women before and after 
flour fortification with folic acid 
 
Figure 9 present the distribution curves of the studied women by folate intake before and 
after flour fortification. After flour fortification with folic acid, almost half of the women 
received 400 μg folic acid per day . 
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Figure 9 : Distribution curves of the studied women by folate intake  before and after flour 
fortification. The vertical line shows folate intake equal to RDA( 400μg/day  ) 
 
 
 
Figure 10 shows the correlation between folate intake and serum folate in the studied 
women. Folate intake was positively correlated with serum folate concentrations in the 
pre- and post-fortification period (r = 0.084; p<0.05) .As this figure shows by increasing 
the folate intake, serum folate has increased significantly. 
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Figure 10: Correlation between folate intake and serum folate of the studied women , before and 
after flour fortification 
 
From the result presented in table 18 , we can observe a significant decline in the mean 
intake of vitamin B12 after flour fortification that was from 2.6μg/day in the pre-
fortification period to 1.7μg/day in the post –fortification period( p=0.009).  
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Table 18 : Mean of vitamin B12 intake of the studied women before and after flour 
fortification 
 
*December 2006              
   †December 2008 
∞Due to assessment method (single 24-h-recall) and assigned zero-values for all plant foods in the 
food composition database considering that all plant foods consumed contained no cobalamin 
 
As table 19 shows, vitamin B12 intake in 48.1% and 51.9%of the women was lower than 
the RDA (2.4 μg /day) in the periods of before and after flour fortification, respectively. 
The difference between the prevalence of low vitamin B12 intake in the pre-fortification 
and post- fortification period was not significant (p=0.4).  
 
Table 19: Distribution of the studied women by vitamin B12 intake, before and after 
fortification 
 
 
Pre-fortification 
* 
 
 
     Post-
fortification † 
 
        
       Total 
 
P 
value 
 
Vitamin B12 
    (μg / day) 
 
n 
% n % n % 
Low∞ 
 
351 48.1 379 51.9 730 100 
Normal 
 
206 49 214 51 420 100 
Total 
 
557 48.4 593 51.6 1150 100 
 
 
0.4 
*December 2006            
   †December 2008 
∞ <2.4 μg / day 
 
95% Confidence 
Interval 
Vitamin B12 
   (μg / day) 
n Mean  
Lower 
Bound 
Upper 
Bound 
2.5 
percentile 
97.5 
percentile 
 
P value 
 
Pre-fortification * 
 
Post-fortification † 
 
Total 
 
 
557 
 
594 
 
1151 
 
2.6 
 
1.7 
 
2.1 
 
1.9 
 
1.5 
 
1.8 
 
3.2 
 
1.8 
 
2.4 
 
0.0∞ 
 
0.0 
 
0.0 
 
7.9 
 
5.9 
 
6.7 
 
0.009 
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We examined whether low serum vitamin B12 in the studied women was correlated to 
vitamin B12 intake, but did not find a significant correlation. 
 
4.3. Trend of NTDs prevalence before and after flour fortification 
 
Between September 2006(pre-fortification period) and December 2008 (post –
fortification period), 35 NTD cases were recorded, of which spina bifida was the most 
common type of anomaly (51.4%), followed by anencephaly (48.6%).  
As the results presented in table 20 , it can be observed that the overall prevalence of 
NTDs decreased from 3.16 per 1000 births including live births and stillbirths , before 
flour fortification (September 2006-July 2007) to 2.19 per 1000 births during the full-
fortification (December 2007-December 2008) period (RR 0.09, 95% CI 0.042 - 0.21) 
that was statistically significant (P-value<0.01). 
The total annual rate of NTDs significantly declined by 31% (95%CI  26%-35% ) after 
the implementation of folic acid fortification (P <0.01) . As table 19 shows, although the 
prevalence rate of NTDs has been significantly declined after flour fortification with folic 
acid , still there is a high prevalence rate of NTDs in Golestan province ( 2.19 per 1,000 
births). 
Our finding shows that the prevalence rate of spina bifida declined from 1.75 per 1000 
birth before fortification to 1.09 per 1000 birth after fortification (38%). At the same 
time, the prevalence of anencephaly decreased from 1.68 per 1000 birth to 1.09 per 1000 
birth (35%). These differences were not significant.  
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Table 20: Prevalence rate of NTDs before and after flour fortification  
 
 
Period 
 
No. of births 
 
No. of NTDs∞ 
Rate per 1000 
births 
P value 
Before 
fortification* 
period 
 
4750 
 
15 
 
3.16 
Transition 
period** 
3154 8 2.54 
 
 After fortification 
period† 
 
5457 
12  
2.19 
Total 
 
13361 35 2.62 
 
 
 
 
p<0.01 
 
* September 2006 –July 2007 
  **July - November 2007 
†December 2007-December 2008 
∞ Live and still births 
 
We examined association between the selected socio-demographic characteristics of 
mothers and NTD. There was not a significant difference between mother's age ( p = 
0.579), level of education ( p = 0.346), taking of folic acid supplement (p = 0. 481)  , 
smoking ( p = 0.721)  and  the incidence of NTDs ,before and after flour fortification 
periods . 
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Figure 11.Rates of NTDs, September 2006 ( before flour fortification) – December 2008( after 
flour fortification) ,28 months moving average rate 
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5. Discussion  
 
In this population based study the effectiveness of the public health strategy of flour 
fortification with folic acid was evaluated and possible adverse effects resulting from 
fortification were determined in women of child bearing age. 
This study was undertaken in Golestan province in the north of Iran, due to the 
historically high rates of NTDs. We assessed whether the response in serum folate and 
plasma homocysteine as the markers of folate status were associated with fortified bread 
consumption. 
The mean daily intake of naturally occurring folate was calculated by using a 24-h recall 
questionnaire, in the periods before and after flour fortification. For assessing the 
additional folic acid intake, the mean consumption of bread as the main source of folic 
acid was calculated. Furthermore, the average additional daily intake of folic acid from 
fortified breads was determined by measuring folic acid in the fortified bread, for the 
period after flour fortification. 
The results of the present study demonstrate that the mean intake of natural food folate is 
almost half of the recommended levels, indicates that the women in childbearing age can 
not reach to the optimal folate intake through diet. The mean daily intake of naturally 
occurring folate among studied women in the present study (during pre and post flour 
fortification periods) is higher than the folate intake in Dutch women (Konings, etal, 
2001) but lower as compared to Austrian (Elmadfa and Freisling ,2004) and Canadian 
women (Shiliang, etal, 2004) .However this  finding is similar to intake data of Finnish 
women (Alfthan, etal,2003). 
The mean folate intake of the studied women after fortification (413.7μg/day) is 
consistent with the mean folate intake (427μg/day) of women in Chili after implementing 
flour fortification with folic acid (Hertrampf and Cortes, 2004).  
The results of the present study indicate that flour fortification with folic acid has 
increased typical folic acid by an average 226μg/day, due to consumption of fortified 
bread in women of childbearing age. The maximum dietary intake of folic acid due to 
flour fortification was 570μg / day, based on the maximum amounts of consumed bread. 
When we considered the percentiles of 97.5 and 99 for the total folate intake (794.2 
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μg/day and 919.5 μg/day, respectively).The possible risk of high folate intake (> 
1000μg/day) due to flour fortification with folic acid would be at the maximum level of 
1% of this population. 
The current study shows that there was no significant difference in folate intake from 
naturally occurring sources in the pre and post fortification period and suggests that any 
change in folate status is the result of folic acid added to bread as part of the mandatory 
flour fortification policy in Iran. On the other hand, there was not a significant difference 
between the amount of bread consumption before and after flour fortification (p = 0.821). 
It indicates that the amount of bread consumed was not changed significantly in the pre-
fortification and post- fortification periods and increase in the folate intake is because of 
fortified bread with folic acid. Additionally due to the non availability of any other 
fortified food products with folic acid in Iran and, no folic acid supplements were taken 
by any of the studied women, we can conclude that the wheat bread fortified with folic 
acid was the main source of this nutrient in the studied population. Considering that folic 
acid fortification is restricted to only two kinds of flour which are used for baking flat 
breads, the possibility of high folic acid intake due to consuming fortified bread is low. 
The results of this study are consistent with those who found the potential of a mandatory 
fortification policy to improve folate intake and folate status of women in child bearing 
age ((Ray etal, 2002, Hirsch etal, 2002, Ganji and Kafai , 2005)  to a similar degree as 
achieved in this study.  
In this study serum folate and plasma homocysteine as biomarkers of folate intake and 
folate status are used .The results show that due to flour fortification with folic acid, the 
prevalence rate of low serum folate (<6.7nmol/L) decreased by 84% in the studied 
women.  
The results are similar to the finding by Ganji who showed 91% reduction in the low 
serum folate in the United States (Ganji and kafai , 2005). Hickling reported 56% decline 
in the subjects with low serum folate (Hickling etal, 2005).  
We found 25 % increase in the mean serum folate in the studied women after flour 
fortification. Although this findings disagrees from Jacques who reported 57% increase in 
the mean serum folate in a population of middle aged (Jacques etal, 1999) and Lawrence 
who reported 71% increase in median serum folate values in Kaiser clients residing in 
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Southern California (Lawrence etal, 1999), however consistent with Hickling who 
showed 38%  increase in the mean serum folate after introduction of voluntary folate 
fortification policy in Australia (Hickling ,2005) . Different degrees of improvement 
observed in these studies may be due to the length of exposure to folic acid. 
The results of this study show the increase of 4.5 μg/l in serum folate under mandatory 
folic acid fortification in Golestan province , which is higher than the measured increase 
in serum folate (3.8μg /l) under mandatory folate fortification policy  reported by Ray in 
Canada (Ray etal, 2002) and voluntary folate fortification in Australia (2.8 μg/l) ( 
Hickling etal,2005), and lower than the measured increase in serum folate in USA (5.4 
μg/l) ( Jacques etal, 1999) and in Chile that was7.2 μg/l (Hirsch etal,2002).  
Only those subjects who had fasted ≥ 12 h was included for the reason that folate 
concentration measured in a fasted state is a better indicator of folate status (Ganji and 
Kafai 2005) , and there is evidence that  serum folate in fasting blood sample is good for 
assessing folate status  as red blood cell folate at the population level . A good correlation 
between serum folate and red cell folate has been reported (Galloway and Rushworth, 
2003). The advantage of measuring serum folate is that, it is easier to perform and less 
expensive. 
Folate intake was positively correlated with serum folate concentrations in the pre- and 
post-fortification period .Serum folate is an indicator of recent folate intake (National 
academy of Sciences, 2000) and the food intake data were collected through a 24-hour-
recall, also representing recent intake. 
Findings of the present study show a significant reduction in the mean Hcy 
concentrations of the studied women by 56% (p = 0.000), which is in accordance with the 
Jacques who reported a reduction by 52% in the mean Hcy concentrations in the studied 
women (Jacques etal, 1999). On contrary , Hickling found 21% reduction in mean Hcy in 
the studied population after introduction of the voluntary folate fortification policy in 
Australia (Hickling etal,2005) and Ganji reported 16.1% reduction in the mean Hcy 
concentrations after folic acid fortification in the United States (Ganji and Kafai ,2005).  
The results reflect that after flour fortification with folic acid , homocysteine correlated 
better with serum vitamin B12 levels (r = - 0.208 ; p = 0.000) than with serum folate 
levels (r = - 0.171, p = 0.000). Similarly, Hirsch reported a better correlation between 
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homocysteine and serum vitamin B12 levels than with serum folate levels, 6 months after 
flour fortification with folic acid (Hirsch etal, 2002). Results of this study  support the 
finding by the other researchers that, since folic acid fortification vitamin B12 has 
become the main  determinants of  plasma homocysteine  in postfortification populations( 
Robertson,etal, 2005) or, in subjects with optimized folate status( Quinlivan , etal, 2002). 
A mandatory folate fortification policy, which can reach a greater proportion of the 
population, is likely to result in a wider spread increase in serum folate and a greater 
decrease in Hcy concentrations. 
Findings show a considerable reduction in the prevalence rate of hyperhomocysteinemia, 
from 38.3% to 7.3% in the studied population (88%). 
This result is consistent with other findings. Hirsch reported a significant reduction in 
hyperhomocysteinemia, from 31% to 17%, 6 months after flour fortification with folic 
acid (Hirsch, etal , 2001) . Jacques also reported a reduction of high Hcy concentrations 
from 18.7% to 9.8% (Jacques etal, 1999). 
In our study, the decrease in the mean plasma homocysteine concentrations that is 5.5μ 
mol/l is higher than the measure decrease in the mean plasma homocysteine in Australia 
that is 2.1μmol/L ( Hickling etal,2005) .Results of the present study indicate that the 
mean Hcy concentrations of the studied women (7.1mol/L) fell with in the lower end of 
normal range (Ueland etal 1993) and reflected the positive folate balance of these 
women.  
This improved folate status in current study, remained significant after adjusting the 
analysis for socio-demographic characteristics of the women.  
Assessing serum folate concentrations , demonstrate that with increasing folate intake due 
to fortified bread, there was a significant increase in the proportion of women achieving 
optimal folate status ( i.e., a serum folate value > 6.7 nmol/l; Sauberlich 1999).  
It is not possible that the observed differences in serum folate status resulted from 
variations in folate intake that was unrelated to fortification. However, we adjusted serum 
folate values for folate dietary intake and therefore we are confident that the changes seen 
in serum folate status can be ascribed to folic acid fortification. 
Blood folate levels are still an intermediate outcome, and the real measure of the impact 
of increased folic acid consumption is the reduction of NTDs rates. 
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The current study shows 31% reduction in the prevalence rate of NTDs after flour 
fortification.  
This observation is similar to reports from other countries where fortification is taking 
place. The reduction in the NTDs rate after implementation of fortification  in our study 
is greater than the 19% reduction in the prevalence of NTDs in the US after mandatory 
fortification ( Honein etal 2001) but lower than the 78% reduction in Newfoundland (Liu 
etal , 2004) and 54% reduction in rate of NTDs reported in Nova Scotia after fortification 
( Persad eatl, 2002). Similar to our results, 32% reduction in NTDs in Quebec was 
reported (De Wals etal, 2003). Also, Bower has explored 30% reduction in NTDs after 
folic acid fortification in Western Australia (Bower etal, 2002). Similar to our study, 
Honein etal, reported a non significant reduction in spina bifida and anencephaly after 
mandatory flour fortification in US. Evidence from several European populations shows 
that, in the absence of mandatory folic acid fortification, public health strategies to 
prevent NTDs have been ineffective (Botto etal, 2005, Busby etal, 2005).  
Findings, therefore, support the view expressed by many that mandatory fortification 
with folic acid is the only means of ensuring that all women of reproductive age can 
benefit in terms of reduced risk of NTDs. Decline in NTDs prevalence rate in our study 
was also consistent with the observed increase in serum folate levels and folic acid intake 
in the women of reproductive age after flour fortification with folic acid. 
Our Findings confirm that, mandatory flour fortification in Iran would be effective in 
reducing NTDs risk in women who regularly consume fortified bread.  
According to our findings, we believe that a significant decrease in prevalence rates of 
NTDs is corresponding to the implementation of flour fortification with folic acid. The 
limitation of our study is that it was carried out in a referral center and we did not include 
spontaneous abortion caused by NTDs as it was difficult to obtain the data.  
Although the prevalence rate of NTDs has been significantly declined after flour 
fortification with folic acid , still there is a high prevalence rate of NTDs in Golestan 
province ( 2.19 per 1,000 births). We found 31% reduction in the NTDs prevalence after 
folic acid fortification, it means that not all NTDs are related to folic acid, and that other 
genetic and nutritional factors such as vitamin B12 and Zinc may play an important role. 
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Researchers have shown the role of maternal  vitamin B12 deficiency (Ray etal, 2007) as 
potential risk factor for NTDs. 
In theory, the potential role of vitamin B12 in preventing NTDs and other congenital 
anomalies is explicable by its metabolism. Vitamin B12 interacts with folic acid in the 
remethylation of homocysteine to methionine , a key metabolic reaction in the function of  
folic acid. More recent studies have made use of better biomarkers of vitamin B-12 status, 
including methylmalonic acid and holotranscobalamin (holoTC). 
By assessing Holo TC that represents the bioavailable  fraction of circulating vitamin B-
12, Thompson  in a large Canadian cohort accrued before and after folic acid fortification,  
found a 3-fold increase in the risk of NTDs in mothers who had vitamin B-12 status in the  
lower quartile, regardless of folic acid fortification (Thompson etal, 2009). 
 
High plasma Homocysteine may play an independent role in the development of NTDs. 
Felkner suggested that high homocysteine levels have a detrimental effect on NTD-risk 
even when serum B12 or red blood cell folate levels are high ( Felkner etal, 2009).Three 
B vitamins are involved in  homocysteine metabolism: the biological active form of 
vitamin B6 as a co factor for the enzyme cystathionine ß synthase, vitamin B12 as a 
cofactor for methionine systhase , and 5- methyltetrahydrofolate a substrate. The 
formation of methylltetrahydrofolate is catalyzed by methylenetetrahydrofolate reductase 
(MTHFR), a vitamin B2-dependent enzyme (Finkelstein, 1990). Homocysteine 
metabolism plays an important role in so - called one-carbon metabolism providing 
methyl groups to all kinds of substance, including the synthesis and regulation of DNA 
and mRNA, which are essential for embryonic cells (Massaro and Rogers, 2002). A 
possible derangement of folate-dependent homocysteine metabolism in women who had 
NTD offspring has been reported (Steegers-Theunissen etal, 1991).The derangement of 
homocysteine metabolism in mothers with NTD offspring is based on gene mutations of 
the MTHFR enzyme. A change of alanin to valine at the 225th amino acid of MTHFR 
decrease the activity of this enzyme by 35% (Engbersen ,etal, 1995). The mutation 
predisposes to mild hyperhomocysteinemia in the presence of a low folate status 
(Kluijtmans etal, 1996). A shortage of MTHFR as a result of the C677T mutation located 
on chromosome 1 in families with NTD has been found (Van der Put etal, 1995).  
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There are different ethnic groups in Golestan province and it is necessary to determine 
the prevalence of the genetic mutation C677T in these ethnic groups. The C677T 
mutation is associated with an elevated plasma homocysteine and a low folate status 
(Massaro and Rogers, 2002). Also, other genes involved in folate-homocysteine 
metabolism and their interaction should be investigated in this province.  
Zinc deficiency is another factor that may result NTDs. Animal model studies have 
shown that hepatic methionine synthase activities were increased in zinc deficient rats. 
This increased resulted in a decreased 5- methyltetrahydrofolate in the liver of zinc 
deficient rats . Furthermore, plasma folate and homocysteine were lower in zinc deficient 
rats (Hong eatl, 2000). Also, folate and Homocysteine metabolism in copper deficient 
rats, has shown that hepatic methionine synthase activity in the copper deficient group 
was significantly lower. The percentage of 5- methyltetrahydrofolate in total hepatic 
folate in the copper deficient group was significantly higher (Tamura etal, 1999). All of 
these changes in folate metabolism in zinc or copper deficiency are likely to be secondary 
to the alterations in methionine synthase activity (Massaro and Rogers, 2002).In humans, 
it may be reasonable to that decreased folate concentrations in the maternal circulation 
with zinc deficiency, result in decreased placental folate transfer; thus, compromised 
folate may lead to fetal growth retardation or malformations of the central nervous 
system (Massaro and Rogers, 2002). Association between presence of NTDs and zinc 
deficiency in newborns affected with NTDs also, has been reported (Carrillo- Ponce ,etal, 
2004).  
In Golestan province, Golalipour reported the association between NTDs and maternal 
zinc deficiency (Golalipour etal, 2009 ). Due to using  small sample size  in this study , 
further researches with large enough sample size is needed to confirm the role of zinc 
deficiency in the prevalence of NTDs in this province. 
The other factor that may have a role in the NTDs prevalence in Golestan province , 
could be vitamin B2 ( riboflavin) deficiency, since , a high prevalence of low vitamin B2 
intake , has been reported in Iran (Ministry of Health & Medical Education ,2001). 
Studies demonstrated that low plasma riboflavin concentrations are associated with 
higher plasma total homocysteine concentrations. The relationship is confined to 
individuals who have both lower circulating folate concentrations and are homozygote for 
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the MTHFR C677T polymorphism. MTHFR converts methylenetetrahydrofolate to 
methyltetrahydrofolate, which is required for the methylation of homocysteine to 
methionine; riboflavin, in the form of flavin adenine dinucleotide (FAD), is a cofactor for 
MTHFR (Jacques etal, 2002). 
In those countries where, enriched flour and grain products include riboflavin, riboflavin 
status would not appear to be an important determinant of circulating Hcy concentration. 
However, the importance of riboflavin as a determinant of homocysteine should not be 
underestimated in other countries, particularly where the prevalence of inadequate folate 
and riboflavin intakes is more common. 
Current study examined whether folic acid fortification would mask vitamin B12 
deficiency .The reason is that vitamin B12 and folic acid have the same metabolic 
pathway and additional folic acid could correct the hematological signs of vitamin B12 
deficiency and postpone clinical diagnosis, which could lead to neurological damage. 
The metabolic interrelationship between folic acid and vitamin B12 suggests that when 
the folate cofactor 5- methyltetrahydofolate (THF) is formed, the enzyme 5,10-
methyleneTHF reductase that forms the cofactor cannot use it in the back reaction in vivo 
(the methyl trap hypothesis). Thus, the only way for this folate cofactor to be recycled to 
THF (and thus participate in DNA biosynthesis and allow cell division), is through the 
vitamin B12-dependent enzyme methionine synthase . When the activity of the enzyme is 
compromised, as it would be in Pernicious Anaemia (PA), the cellular folates will 
become progressively trapped as 5-methylTHF. The consequence will be an anemia 
identical to that seen in true folate deficiency. Thus, in PA there will be a neuropathy 
and/or anaemia. Treatment with vitamin B12, if given intramuscularly, will reactivate 
methionine synthase, allowing myelination to restart. The trapped folate will also be 
released, thus allowing DNA synthesis and generation of erythrocytes, redressing the 
anaemia. It is known that treatment with high concentrations of folic acid will also treat 
the anaemia but not the neuropathy in PA, because when folic acid enters the cell it is 
first converted via dihydrofolate to THF .However, administration of folic acid cannot do 
anything to restart the methylation cycle, blocked as it is at the vitamin B12-dependent 
enzyme methionine synthase. Thus, the neuropathy will continue (masking vitamin B12 
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deficiency), only to be diagnosed later when treatment with vitamin B12 may only partly 
reverse the nerve damage (Cuskelly etal, 2007). 
The present study did not find the evidence of masking vitamin B12 deficiency after folic 
fortification.  
This finding is in agreement with Mills findings which showed no increase in the number 
of subjects with a combination of low vitamin B12 concentrations and no macrocytosis 
after the introduction of folic acid fortification (Mills etal , 2003).On the other hand, 
Wyckoff reported that the proportion of the subjects with low serum vitamin B12 
concentration but without macrocytosis increased after flour fortification with folic acid ( 
Wyckoff,2007).  
Our results provide important reassurance that folic acid exposure due to flour 
fortification has not resulted in an increase in the proportion of women with a low serum 
vitamin B12 concentration but normal MCV values.  
Due to the non availability of any data on vitamin B12 status of the women of child 
bearing age in this province, we assessed vitamin B12 status of the women in the present 
study. We found a high prevalence of low serum B12 among the women of child bearing 
age both in the pre –fortification and post- fortification period. The result demonstrates 
that the prevalence rate of vitamin B12 deficiency was higher even after flour 
fortification.  
A significant increase in the mean serum vitamin B12 levels in Canadian women aged 
19-44 was reported one year after folic fortification (Liu, etal, 2004). It is disagree with 
those of (Hertrampf and Cortes , 2004), who reported no changes in the vitamin B12 
distribution curves of Chilean women of childbearing age after flour fortification with 
folic acid . 
A high rate of vitamin B12 deficiency was reported 9 years after the implementation of 
Canadian folic acid flour fortification (Ray, etal, 2008) . High prevalence rate of vitamin 
B12 deficiency , as we found in our study , shows that Vitamin B12 status of population  
has to be considered when a folic acid fortification program is being implemented.  
This study was unable to demonstrate a significant correlation between vitamin B12 
intake and serum B12, whereas other studies have reported a strong positive association 
between serum B12 and a dietary pattern that included frequent intake of animal food 
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sources (Villamor etal, 2008).The results of this study show that vitamin B12 intake in 
almost 50% of the women was lower than the recommended level in the periods of before 
and after flour fortification, respectively. A possible explanation for vitamin B12 
deficiency in this studied population might be low consumption of Vitamin B12 rich food 
sources. There are, however, other possible explanations such as H. pillory infection, 
giardiasis (Olivares etal, 2002) and self treatment by anti acid drugs . 
The mean daily (µg) vitamin B12 intake of Iranian women in the present study was lees 
as compared to the women in European countries, such as Finland (7.4 µg), Denmark 
(4.3 µg), United Kingdom (5.4 µg), Ireland (3.6µg), Netherlands (4.3 µg), Germany (4.7 
µg), France (6.3 µg), and Spain (4.9 µg) (Dhonukshe- Rutten , etal,2007). 
Higher dietary intake of vitamin B12 in European women as compared to Iranian women 
may be explained by higher socio-economic status which leads to increase consumption 
of animal protein in European populations. Serum vitamin B12 concentrations in these 
countries are also higher (Dhonukshe- Rutten , etal,2007). 
It is assumed that vitamin B12 deficiency is unlikely to occur except under special 
circumstances, such as vegetarianism, elderly period, food-cobalamin malabsorption 
syndrome, Helicobacter Pylori infection, and intestinal microbial proliferation, which can 
be caused by antibiotic treatment. Nevertheless, recent studies have shown a high 
prevalence of serum vitamin B12 deficiency in different population groups such as school 
children (Rogers etal,2003) and both adult men and women (Allen 2004). 
In developing countries, low serum vitamin B12 concentrations could be a consequence 
of reduced consumption of animal protein due to its high cost. According to the Food and 
Agriculture Organization of the United Nations (FAO), per capita supply of animal 
products in developing countries constitutes less than one third of the documented supply 
in industrialized countries (Jetzi , 2003).  
Our findings suggest that vitamin B12 status of general population should be monitored, 
during folic acid fortification in developing countries, where the probability of vitamin 
B12 deficiency is high. Vitamin B12 is a risk factor, independent of folate status, in 
NTDs occurrence especially in the era after folic acid flour fortification. Further work is 
required to establish this, and possibly, considering adding vitamin B12 to folic acid 
fortified flour. 
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We may have underestimated nutrient intakes because of the known fact of 
underreporting in self-reported dietary intake measurements. A particular disadvantage of 
the 24-hour-recall method, which was used in this study, is the difficulty of determining 
whether the day being recalled represents an individual's typical intake because of day-to-
day variation in intakes of individuals. However, mean intake of energy and nutrients of a 
population should be unaffected against individual day-to-day variation of dietary intake. 
One the other hand, advantages of a single recall are ease in administration at the 
population level, minimization of biases associated with altering food intake because of 
knowledge that one is being observed, and the low interview burden. Regarding to 
vitamin B12 intake, because vegetarianism in our study region is uncommon, we consider 
gross underestimation to be unlikely. 
Although this was an observational study and therefore can not confirm a causal relation, 
the higher serum folate status and lower Hcy concentrations observed in the studied 
women were the direct result of fortification rather than a generalized positive dietary 
pattern. In support of this, we found no difference in natural food folate intakes at 
baseline and after flour fortification. Only folic acid intakes were found to increase and 
fortified bread was the only source of the latter. 
Limitations 
 
An important limitation of this study lies in the use of serum B12, although the indicators 
such as methylmalonic acid (MMA) are more sensitive (Ubbnik, etal, 1991). However, 
the high cost of this test at the population level constrained the use of this test. On the 
other hand, MMA can be elevated by intestinal bacterial overgrowth (Lindenbaum,etal, 
2006) resulted over estimation of B12 deficiency. More over, there is an increasing 
interest in the diagnostic value of plasma holotranscobalamin concentrations. However, 
there is usually a strong correlation between total serum B12 and holo TC in populations 
(Clark etal, 2007 and Shahab –Ferdows etal, 2008) .Thus, considering the higher cost of 
the holo TC assay; it was more practical for this study to rely on serum B12 for the 
estimation prevalence of vitamin B12 deficiency in the studied population. 
Another limitation of the current study is that the dietary data was derived from a single 
24-hour-recall, which has limitations regarding the assessment of the prevalence of 
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nutrient inadequacy in a population group. Food consumption data were obtained from a 
single day. There are possibilities that quantitative assessment of folate intake may not be 
accurate enough and / or underestimation of folate intake, because, assessing of dietary 
folate is complicated by data gaps in food composition tables, variations between 
methods used for folate analysis, and limited understanding of the bioavailability of food 
folate.  
The studied population could have changed over the course of the study. There were, 
however, no major changes in the socio demographic and health status of the studied 
population and no significant difference in confounding variables were found. 
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6. Summary 
Folic acid is an important nutrient for women in childbearing age. Adequate folate intake 
during the peri-conceptional period, the time right before and just after a woman becomes 
pregnant, helps protect against a number of congenital malformations including Neural 
Tube Defects (NTDs) which are the most notable birth defects that occur from folate 
deficiency. 
Folic acid fortification has been suggested as a main strategy to control and reduce the 
prevalence of NTDs. The aim of this research was to study the effects of folic acid 
fortification on reduction of NTDs and improve folate status of Iranian women in 
childbearing age .This study were conducted before and after mandatory flour 
fortification (2006-2008) with folic acid in the Golestan province located in the north of 
Iran, which has a high prevalence of NTDs. Two cross sectional study as base line (pre-
fortification period) and final evaluation (post –fortification period) were conducted .In 
each phase, biochemical indicators of folate status, socio demographic , health 
characteristics and dietary intake were studied in 600 women of child bearing age as 
representative sample of women in Golestan province and, the results were compared. 
Diet was assessed by a single 24-h-recall, covered all days of the week, including 
weekends. The final dietary intake data were validated in the Department of Nutritional 
Sciences, University of Vienna, Austria, by comparing the nutrient content of selected 
food items, representative of the average Iranian diet, with the food composition data of 
the Austrian food composition database. 
Additionally, a longitudinal hospital based study 12 months before and 12 months after 
flour fortification was conducted to determine the trend of NTDs .The results show that 
due to flour fortification with folic acid, prevalence of low serum folate decreased by 
84% and the mean serum folate showed 25% improvement after fortification (from 
13.6nmol/L to 18.1nmol/L; p=0.000). The findings of this study show  88% reduction in 
the prevalence of hyperhomocysteinemia (from38.8% to 7.3 %; p = 0.000). This 
improved folate status remained significant after adjusting the analysis for socio-
demographic characteristics of the studied women.  
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Assessing serum folate concentrations, demonstrate that with increasing folate intake due 
to fortified bread, there was a significant increase in the proportion of women achieving 
optimal folate status.  
In the present study ,the trend of NTDs was determined , before and after flour 
fortification with folic acid , as the impact of folic acid fortification in Golestan province. 
Total prevalence rates were calculated as a total number of NTD per 1000 births. Time 
trend analysis of monthly NTD rates was performed. All live births and stillbirths (a 
gestational age of ≥20 weeks and ≥500 g who were admitted in neonatal intensive care 
unit (NICU) of Dezyani teaching hospital were included from September 2006 (before 
flour fortification) to December 2008 (after flour fortification).  
The current study shows 31% reduction in the prevalence rate of NTDs after flour 
fortification from 3.16 per 1000 births to 2.19 per 1000 births (RR 0.09, 95% CI 0.042 - 
0.21) that was statistically significant (P-value<0.01). Decline in NTD prevalence rate in 
this study was also consistent with the observed increase in serum folate levels and folic 
acid intake in the women of reproductive age after flour fortification with folic acid .This 
Findings confirm that, mandatory flour fortification in Iran, would be effective in 
reducing NTD risk in women who regularly consume fortified bread.  
We examined whether folic acid fortification would mask vitamin B12 deficiency .The 
reason is that vitamin B12 and folic acid have the same metabolic pathway and additional 
folic acid could correct the hematological signs of vitamin B12 deficiency and postpone 
clinical diagnosis, which could lead to neurological damage . 
We did not find the evidence of masking vitamin B12 deficiency after folic fortification. 
The proportion of women without macrocytosis was higher after flour fortification 
(82.9%) than before flour fortification (80%), and the difference was not significant (p = 
0.370). Our results provide important reassurance that folic acid exposure due to flour 
fortification has not resulted in an increase in the proportion of women with a low serum 
vitamin B12 concentration but normal MCV values.  
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Our findings, therefore, support the view expressed by many that mandatory fortification 
with folic acid is the only means of ensuring that all women of reproductive age can 
benefit in terms of reduced risk of NTDs. 
We found a high prevalence of low serum B12 among the women of child bearing age 
both in the pre –fortification and post- fortification period. On the other hand, vitamin 
B12 intake in almost 50% of the women was lower than the RDA (2.4 μg /day) in the 
periods of before and after flour fortification, respectively. Our findings suggest that 
vitamin B12 status of general population should be monitored, during folic acid 
fortification in developing countries, where the probability of vitamin B12 deficiency 
could be high. Vitamin B12 is a risk factor, independent of foate status, in NTDs 
occurrence especially in the era after folic acid flour fortification , Consideration should 
be given to confirm our finding , and possibly , to the adding of B12 to folic acid fortified 
flour. 
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7. Zusammenfassung 
Folsäure ist ein kritischer Nährstoff für Frauen im gebärfähigen Alter. Eine adäquate 
Aufnahme in der Zeit um die Empfängnis beugt der Entstehung einer Reihe angeborener 
Missbildungen wie vor allem Neuralrohrdefekten (NRD), die zu den häufigsten Folgen 
eines Folatmangels in der Schwangerschaft zählen. 
Eine Anreicherung von Lebensmitteln mit Folsäure wurde als entscheidende Maßnahme 
zur Verminderung des Auftretens von NRD vorgeschlagen. Im Iran wird eine gesetzlich 
vorgeschriebene Anreicherung des Mehls in Erwägung gezogen, um die Versorgung der 
Bevölkerung mit Mikronährstoffen zu verbessern. Bislang gab es allerdings keine 
Interventionsstudien, um die Wirksamkeit und Sicherheit einer Anreicherung durch 
Zugabe von 1,5 ppm Folsäure zu Weizenmehl im Iran zu überprüfen. Die hier 
vorgestellte Arbeit umfasst zwei in der Provinz Golestan im Norden des Irans 
durchgeführte Querschnittstudien. Diese Region verzeichnet ein hohes Auftreten von 
NRD und wurde für ein Pilotprojekt ausgewählt, im Rahmen dessen von 2006 bis 2008 
eine gesetzlich vorgeschriebene Mehlanreicherung mit Folsäure und Eisen stattfand. Die 
beiden Studienreihen wurden jeweils vor Beginn und am Ende der Intervention angesetzt, 
um die Auswirkungen der Anreicherung auf das Vorkommen von NRD und das Risiko 
einer Verschleierung eines B12 Mangels zu untersuchen. 
In beiden Phasen wurden biochemische Marker des Folatstatus gemessen sowie 
soziodemographische, gesundheitliche und Daten zum Nahrungsmittelverzehr einer für 
die Golestan-Provinz repräsentativen Stichprobe von 600 Frauen im gebärfähigen Alter 
erhoben. Vergleiche der Ergebnisse aus beiden Studien sollten Aufschluss über 
Veränderungen des Folatstatus infolge der Anreicherung geben. Die Nahrungsaufnahme 
wurde mittels eines einzelnen 24h recalls erhoben, wobei über die ganze Stichprobe 
verteilt alle Wochentage einschließlich der Wochenenden berücksichtigt wurden. Für die 
Auswertung wurde eine Iranische Nährwerttabelle mithilfe der neuesten Ausgabe der 
Britischen Nährwerttabelle um fehlende Daten zum Folsäuregehalt ergänzt. Eine 
Validierung der so berechneten Aufnahmewerte erfolgte am Institut für 
Ernährungswissenschaften der Universität Wien durch Vergleich mit Österreichischen 
Nährwertdaten. 
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Des Weiteren wurden die Auswirkungen auf das Auftreten von NRD untersucht. Hierzu 
wurden zwischen September 2006 und Dezember 2008, 12 Monate vor und 12 Monate 
nach der Intervention, alle Lebend- und Totgeburten ab einem Gestationsalter von 20 
Wochen und einem Geburtsgewicht ab 500 g, die in der Neugeborenenintensivstation des 
Dezyani Lehrkrankenhauses aufgenommen wurden, berücksichtigt. Die Rate an NRD in 
der Golestan-Provinz wurde als Gesamtfallzahl pro 1000 Geburten berechnet und eine 
Trendanalyse der monatlichen Raten durchgeführt. 
Infolge der Anreicherung verringerte sich die Prävalenz niedriger Serumfolatwerte um 
84%, der mittlere Gehalt stieg signifikant um 25% (von 13,6 nmol/l auf 18,1 nmol/l, 
p=0,000). Das Vorkommen von Hyperhomocysteinämie nahm um 88% ab (von 38,8% 
auf 7,3 %, p=0,000). Diese Effekte blieben auch nach Adjustierung hinsichtlich 
soziodemographischer Merkmale der untersuchten Frauen statistisch signifikant. Die 
Messung der Serumfolatkonzentration zeigte, dass mit zunehmender Aufnahme des 
Vitamins aus angereichertem Brot ein signifikant höherer Anteil an Frauen einen 
optimalen Folatstatus erreichte. 
Hinsichtlich der Häufigkeit von NRD wurde nach der Anreicherung des Mehls mit 
Folsäure eine Verringerung um 31% beobachtet von 3,16 auf 2,19 Fällen pro 1000 
Geburten (RR 0,09, 95% KI 0,042-0,21). Dieser Effekt war statistisch signifikant 
(p<0,01). Die Abnahme der NRD-Häufigkeit entsprach dem beobachteten Anstieg der 
Serumfolatspiegel und der Folataufnahme bei Frauen in gebärfähigem Alter. Diese 
Ergebnisse bestätigen, dass eine gesetzlich vorgeschriebene Anreicherung von Mehl mit 
Folsäure im Iran eine wirksame Maßnahme zur Verringerung von NRD bei Kindern von 
Frauen, die regelmäßig angereichertes Brot verzehren, darstellt. 
Es wurde auch untersucht, ob die Gefahr einer Verschleierung eines vorhandenen 
Mangels an Vitamin B12 besteht. In der Tat besteht eine Verbindung des Stoffwechsels 
der Folsäure mit jenem von Vitamin B12, da Letzteres für die Regenerierung der 
Folsäure benötigt wird und eine Unterversorgung sekundär zu einem Mangel an Folsäure 
führen kann. Eine Supplementierung mit Folat kann die hämatologischen Symptome 
eines Vitamin B12 Mangels überdecken und die Diagnose erschweren, während die 
neurologischen Schäden bestehen bleiben. 
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In der vorliegenden Stichprobe ergab sich jedoch keine Maskierung eines B12 Mangels 
infolge Anreicherung. 
Der Anteil der Frauen, bei denen keine Makrozytose vorlag, war nach der Anreicherung 
höher als vorher (82,9% gegenüber 80%). Dieser Unterschied war allerdings nicht 
statistisch signifikant (p=0,370). Insgesamt dürfte die Gefahr einer Zunahme des Anteils 
an Frauen mit niedrigen B12 Serumspiegeln und gleichzeitig normalem mittlerem 
korpuskulärem Volumen (MCV) infolge Aufnahme von angereichertem Mehl gering 
sein. 
Zusammenfassend zeigen diese Ergebnisse, dass eine gesetzlich geregelte 
Mehlanreicherung mit Folsäure eine geeignetes Mittel ist, die Versorgung von Frauen in 
gebärfähigem Alter mit diesem Vitamin zu verbessern und so dem Auftreten von NRD 
vorzubeugen, mit dem der überwiegende Teil dieser Zielgruppe erreicht werden kann. 
Sowohl vor als auch nach der Intervention traten niedrige Serumspiegel an Vitamin B12 
häufig auf. Gleichzeitig lag die tägliche Zufuhr in beiden Phasen bei fast 50% der 
untersuchten Frauen unterhalb der empfohlenen Menge von 2,4 µg/Tag. Vitamin B12 
Mangel ist ebenfalls ein Risikofaktor für NRD, unabhängig vom Folatstatus, besonders 
nach Anreicherungsmaßnahmen mit Folsäure. Insofern sollte im Zuge einer 
Lebensmittelanreicherung mit Folsäure in Entwicklungsländern der Vitamin B12 Status 
in der gesamten Bevölkerung überwacht werden, wenn die Gefahr einer mangelhaften 
Versorgung mit diesem Nährstoff gegeben ist. Weitere Studien sind nötig, um diese 
Ergebnisse zu bestätigen und es ist zu erwägen, die Anreicherung des Mehls auf Vitamin 
B12 auszudehnen. 
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